The Influence of Abutment Macro-Design on Peri-Implant Tissue Dimensions for Guided Placed and Restored Implants: A 1-Year Randomized Controlled Trial and CBCT Analysis by Ali, Abdulaziz
Nova Southeastern University 
NSUWorks 
Student Theses, Dissertations and Capstones College of Dental Medicine 
2019 
The Influence of Abutment Macro-Design on Peri-Implant Tissue 
Dimensions for Guided Placed and Restored Implants: A 1-Year 
Randomized Controlled Trial and CBCT Analysis 
Abdulaziz Ali 
Nova Southeastern University 
Follow this and additional works at: https://nsuworks.nova.edu/hpd_cdm_stuetd 
 Part of the Dentistry Commons 
All rights reserved. This publication is intended for use solely by faculty, students, and staff of 
Nova Southeastern University. No part of this publication may be reproduced, distributed, or 
transmitted in any form or by any means, now known or later developed, including but not 
limited to photocopying, recording, or other electronic or mechanical methods, without the prior 
written permission of the author or the publisher. 
NSUWorks Citation 
Abdulaziz Ali. 2019. The Influence of Abutment Macro-Design on Peri-Implant Tissue Dimensions for 
Guided Placed and Restored Implants: A 1-Year Randomized Controlled Trial and CBCT Analysis. Master's 
thesis. Nova Southeastern University. Retrieved from NSUWorks, College of Dental Medicine. (127) 
https://nsuworks.nova.edu/hpd_cdm_stuetd/127. 
This Thesis is brought to you by the College of Dental Medicine at NSUWorks. It has been accepted for inclusion in 
Student Theses, Dissertations and Capstones by an authorized administrator of NSUWorks. For more information, 




THE INFLUENCE OF ABUTMENT MACRO-DESIGN ON PERI-IMPLANT 
TISSUE DIMENSIONS FOR GUIDED PLACED AND RESTORED 





ABDULAZIZ ALI, BCHD. 
 
 
A Thesis Presented to the Faculty of the College of Dental Medicine of 
Nova Southeastern University in Partial Fulfillment of the Requirements for the 
Degree of 




THE INFLUENCE OF ABUTMENT MACRO-DESIGN ON PERI-IMPLANT TISSUE 
DIMENSIONS FOR GUIDED PLACED AND RESTORED IMPLANTS: A 1-YEAR 
RANDOMIZED CONTROLLED TRIAL AND CBCT ANALYSIS. 
By 
ABDULAZIZ ALI, BChD. 
A Thesis Submitted to the College of Dental Medicine of Nova Southeastern 
University in Partial Fulfillment of the Requirements for the Degree of 
MASTER OF SCIENCE 
Department of Periodontology 
College of Dental Medicine 




Approved as to style and content by: 
 
APPROVED BY:________________________________________________________ 
                               Dr. Theofilos Koutouzis, D.M.D., M.S.                                 Date 
 
APPROVED BY:________________________________________________________ 
                               Dr. Maria Hernandez, D.M.D., M.S.                                      Date 
 
APPROVED BY:________________________________________________________ 
                              Dr. William Parker, D.M.D., M.S.                                          Date 
 
APPROVED BY:________________________________________________________ 






NOVA SOUTHEASTERN UNIVERSITY 
Health Professions Division 
Department of Periodontology 
College of Dental Medicine 
  
STUDENT NAME: Abdulaziz Ali, BChD. 
STUDENT E-MAIL ADDRESS: aa2221@mynsu.nova.edu  
STUDENT TELEPHONE NUMBER: (954)-401-2343  
COURSE DESCRIPTION: Master of Science  
TITLE OF SUBMISSION: The influence of abutment macro-design on peri-implant 
tissue dimensions for guided placed and restored implants: a 1-year randomized 
controlled trial and CBCT analysis. 
DATE SUBMITED: June 2019  
  
I certify that I am the sole author of this thesis, and that any assistance I  
received in its preparation has been fully acknowledged and disclosed in  
the thesis. I have cited any sources from which I used ideas, data, or  
words, and labeled as quotations any directly quoted phrases or passages,  
as well as providing proper documentation and citations. This thesis was  




SIGNATURE: ____________________________________________________  





To my mom, for believing in me and supporting my pursuit of a career in dentistry. 
To my wife, Nour, for standing by me throughout all the difficulties of studying abroad. I 
could not have done this without her love and support. 
To the government of Kuwait, for providing financial support and giving me the 
















I would like to thank my mentor Dr. Koutouzis, for all his help during the research 
project. His knowledge, expertise and dedication made this 3-year journey in 
Periodontics, worthwhile. 
I would like to extend my gratitude to Dr. William Parker and Dr. Maria Hernandez, for 













THE INFLUENCE OF ABUTMENT MACRO-DESIGN ON PERI-IMPLANT TISSUE 
DIMENSIONS FOR GUIDED PLACED AND RESTORED IMPLANTS: A 1-YEAR 
RANDOMIZED CONTROLLED TRIAL AND CBCT ANALYSIS. 
 
DEGREE DATE: September 2019 
Abdulaziz Ali, BChD. 
COLLEGE OF DENTAL MEDICINE NOVA SOUTHEASTERN UNIVERSITY 
Thesis Directed By:    Theofilos Koutouzis, D.M.D., M.S., Committee Chair 
Maria Hernandez, D.D.D., M.S., Committee Member 
William Parker, D.D.S., M.S., Committee Member 
Abstract 
Introduction: For optimal dental implant esthetics the transition of a circumferential 
implant platform to a proper cervical anatomy has been emphasized. This transition is 
facilitated by the macro-design of the transmucosal portion of the abutment-restoration 
complex at the provisional and final stages of implant prosthetic therapy. There is limited 
information from human studies assessing the impact of abutment macro-design on peri-
implant tissue dimensional changes. Aim: The aim was to evaluate the peri-implant 
tissue levels over a 1-year period for implants connected to either convex or concave final 
abutments at the time of implant placement. Methods: Twenty-eight patients with one 
missing maxillary premolar randomly allocated to receive one single implant with 
abutments of different emergence shape configuration. Patients of the CX Group had 
abutments with convex emergence shape and patients of the CV Group had abutments 
with concave emergence shape. Clinical and radiographic data collected at the time of 




placement (T2). Results: There was 0.42-0.55mm more bone remodeling occurred in the 
CX group. Soft tissue thickness was 21-37% greater in the CV group. There was a 
statistically significant moderate correlation between buccal bone thickness and recession 
T0-T2. No statistically significant difference found in recession between the two groups. 
Conclusion: A concave abutment configuration was associated with less bone 
remodeling and had greater horizontal soft tissue thickness. However, no difference was 
seen in the amount of recession between the two groups. Bone thickness was found to be 
the most significant factor for gingival recess.
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1.1. Dental Implant Success and Survival 
The introduction of dental implants for the treatment of edentulous and partially 
dentulous patients has greatly influenced the practice of modern dentistry, but like any 
new treatment modality, it had to evolve to better suit the patients of the 21st century. 
According to Douglas and Sheets, the modern patient is expected to be more aggressive 
in the expectation of dental treatment, and the dental professionals will be responsible for 
the quality of care provided.1 Patients are looking for not only functional and disease-free 
oral health but also an aesthetically pleasing look for better self-confidence and social 
advantages. 
As such, assessing the survival of dental implants is not enough, since it may not be 
successful. Success represents an implant that meets the criteria on which it is being 
evaluated while survival is when the implant remains in the mouth. The criterion for 
implant success has progressed. In earlier studies the primary concern was regarding the 
osseointegration of the implant, and as to date this still holds true for one of the primary 
successes of dental implants.2 In addition, this reflected on how the initial criterion for 
success was seen in the late 70s and early 80s. Tables 1.1 and 1.2 show the numerous 












Schnitman and Schulman  Cranin et al.  
1. Mobility less than 1 mm in any direction 1. In place 60 months or more 
2. Radiologically observed radiolucency 
graded but no success criterion defined 
2. Lack of significant evidence of cervical 
saucerization on radiographs 
3. Bone loss no greater than one-third of 
the vertical height of the bone 
3. Freedom from hemorrhage according to 
Muhleman′s index 
4. Gingival inflammation amenable to 
treatment; absence of symptoms and 
infection; absence of damage to adjacent 
teeth; absence of paresthesia and 
anesthesia; or violation of the 
mandibular canal, maxillary sinus, or 
floor of the nasal passage 
4. Lack of mobility 
5. Absence of pain or percussive tenderness 
5. Functional service for five years in 75% 
of patients 
6. No pericervical granulomatosis or gingival 
hyperplasia 
 7. No evidence of a widening peri-implant 




Table 1. 2 Implant success criteria of different authors 
 
A major difference in the studies arises from the maximum amount of bone loss that is 
considered successful. Schnitman and Schulman (1979) suggested losing up to a third of 
the total bone height was normal, while McKinney et al. (1984) proposed bone loss no 
greater than a third of the implant was normal. Nonetheless, a widely known success 
criterion by Albrektsson et al. (1986) indicated after the first year, less than 0.2 mm of 
bone loss annually was considered successful. In addition, they indicated dental implants 
should meet these criteria for up to 5 years 85% of the time and up to 10 years 80% of the 
McKinney et al.  Albrektsson et al.  
Subjective criteria 
1. Adequate function 
2. Absence of discomfort 
3. Patient belief that esthetics and emotional and 
psychological attitudes are improved 
 
1. Individually unattached implant that is 
immobile when tested clinically 
Objective criteria 
1. Good occlusal balance and vertical dimension 
2. Bone loss no greater than one-third of the 
vertical height of the implant, absence of 
symptoms, and functional stability after five 
years 
3. Gingival inflammation vulnerable to treatment 
4. Mobility < 1 mm buccolingually, 
mesiodistally, and vertically 
5. Absence of symptoms and infection associated 
with the dental implant 
6. Absence of damage to adjacent tooth or teeth 
and supporting structures 
7. Absence of parasthesia or violation of 
mandibular canal, maxillary sinus, or floor of 
nasal passage 
8. Healthy collagenous tissue without 
polymorphonuclear infiltration 
 
2. Radiography that does not demonstrate 
evidence of peri-implant radiolucency 
3. Bone loss that is < 0.2 mm annually after 
the implant′s first year of service 
4. No persistent pain, discomfort, or 
infection 
Success criterion 
1. Provides functional service for five years in 
75% of implant patients 
 
5. By these criteria, a success rate of 85% at 
the end of a 5-year observation period and 
80% at the end of a 10-year period are 




time to be considered successful. Only one article mentioned an esthetic success 
criterion—which at best was a vague criterion and only indicated there should be an 
improvement of the esthetic, emotional, and psychological attitudes of the patient.3-6 
Recently, the success criteria for implants has changed from the previously mentioned. 
For instance, Misch indicated implant criteria are comparable to that of teeth, which are 
not evaluated whether they are a success or failure. Instead, ideal conditions are reported, 
and a quality of health scale is used to describe the intraoral conditions that should be 
applied to implants. In this health scale, the implants are categorized into either success, 
satisfactory survival, compromised survival, or failure. A successful implant, which 
refers to optimal health, requires specific clinical conditions for the prognosis to be very 
good to excellent. The conditions for optimum health are when the patient has no pain or 
tenderness, no exudate, no implant mobility, and less than 2 mm of bone loss compared 
to when the implant was initially placed. In the survival category, there are two groups: 
satisfactory survival and compromised survival. The satisfactory survival category has 
the same clinical conditions as the success category, except there is a bone loss of 2–4 
mm compared to the initial radiograph. This category has a good to a very good 
prognosis, which is dependent on the future stability of the bone loss. While the 
compromised survival category can have symptoms and a more severe radiographic bone 
loss of 4 mm or less than half of the body of the implant, it has a good to a guarded 
prognosis, depending on how stable the implant can be after surgery. Lastly, the failure 
category indicates the implant must be removed due to any of the following: pain on 
function, exudate, mobility, and radiographic bone loss of more than half of the implant.7 




if further treatment is necessary, but no regards are given to the esthetics of dental 
implants. 
The Pink Esthetic Score (PES) and the White Esthetic Score (WES) are widely used for 
determining implant esthetic failure. The PES objectively assesses five variables: the 
mesial papilla, distal papilla, curvature of the facial mucosa, level of the facial mucosa, 
and root convexity/soft tissue color. The WES objectively assesses the restoration on five 
variables: general tooth form, outline/volume of the clinical crown, color (hue/value), 
surface texture, and translucency/characterization. Each variable is scaled from 0–2, with 
2 being the ideal and 0 being the poorest. Success for these variables is at least six points 
for each and an overall 60% combined.8 
The success of the esthetics and function of dental implants is highly dependent on the 
bone level around the implant. The concept on how much bone loss can be expected 
around an implant has changed dramatically over the years due to the implementation and 
development of better surgical techniques, greater control of systemic local and patient 
factors, and improved implant design. 
1.2. Surgical Factors Affecting Implant Success 
The surgeon’s experience, skills, and knowledge are important for the success of an 
implant. A study by Zoghbi et al. found there was a positive influence of experience on 
the osseointegration of implants. Cases were separated into two groups; the less 
experienced surgeons had placed less than 50 implants while the more experienced 
surgeons had placed more than 50 implants. The more experienced surgeons achieved 




achieved implant osseointegration in 84% of the cases.9 However, other studies compared 
residents in different years of training and clinicians; there was no significant difference 
between the two groups.10, 11 This could be attributed to different reasons; one is the 
number of implants placed does not correlate to the number of years the clinician has 
been in residency. Also, the extensive training of specialized programs may 
accommodate the difference in the amount of implant placement. 
Another factor that is undoubtedly affected by surgical experience is minimizing the 
surgical trauma to the area. A temperature of 47°C or higher during drilling can happen 
within seconds without irrigation. And if this lasts for more than a minute, irreversible 
damage to the bone can occur, leading to soft tissue interface between the implant and the 
bone.12-14 
The knowledge and skills of the surgeon are important for the correct 3D position of an 
implant, which can help prevent bone loss. The surgeon needs to be aware of the 
positioning of the implants in terms of the depth, angulation, and inter-implant and tooth-
implant distance. The proximity of implants to other implants/teeth can affect the 
marginal bone levels; therefore, a general recommendation is a minimum distance of 
3 mm between implants and 1.5 mm between teeth. According to Buser et al., the 
distance between an implant shoulder and tooth root surface should be 1 mm, but due to 
the shape of the implant used in this article, 1.5 mm was recommended.15 If this 
recommendation is not followed, the implant has the risk of attachment loss and 
interproximal recession.16, 17 The more recently used platform-switched implants with a 




loss at different implant distances in platform-switched implants and found no significant 
statistical difference for implants placed 1.97 mm or 3.12 mm apart. 
1.3. Morphogenesis of the peri-implant mucosa in animal studies 
The peri-implant mucosa provides protection for the underlying bone and is an important 
factor for the maintenance of the implant’s stability and function. Most studies on the 
morphogenesis of the peri-implant mucosa have been conducted on animals, and the 
mean values of the peri-implant mucosa are shown in Table 1.3. The peri-implant mucosa 
is composed of the junctional epithelium, approximately 1.5–2 mm, and the connective 
tissue portion, approximately 1–1.5 mm, with greater variations in size at the junctional 
epithelium. The reason why the junctional epithelium does not reach the bone crest is not 
fully understood, but somehow, there must be a connective tissue integration that 
prevents the apical migration of the junctional epithelium to the bone crest. Berglundh et 
al. found no statistically significant difference between the dimension of the epithelium in 
normal teeth compared with that of implants; however, teeth had a statistically significant 









Table 1. 3 Peri-implant mucosal dimensions 










Berglundh et al. 18 2.14 1.66 3.8 Two-stage implant 6 months 
Moon et al. 19 2 N/A N/A Two-stage implant 6 months 





2–2.1 1.3–1.8 2.4–3.65 Two-stage implant 6 months 
Berglundh et al. 22 1.8–2.2 1.5–2 N/A Two-stage implant 4 months 
Berglundh et al. 23 2 1.5 3.5 One-stage implant  12 weeks 
Abrahamsson et al. 24 1.65–2.04 0.85–1.28 2.5–3.32 Two-stage implant 6 months 
Abrahamsson et al. 25 1.85–1.97 1.16–1.18 3.0–3.15 Two-stage implant 6 months 
Abrahamsson et al. 26 2.04 1.28 3.32 One- and two-stage 
implants 
9 months 
Abrahamsson et al. 27 2.1–2.6 1.6 3.7–4.2 Two-stage implant 6 months 
Cochran et al. 28 0.9–1.4 1–1.1 2.0–2.4 Tissue-level 
implants 
12 months 
Hermann et al. 29 1.33–1.75 1.28–1.62 2.84–3.57 Tissue-level 
implants, one- and 
two-stage implants 
6 months 
JE: Junctional Epithelium; CT: Connective Tissue; GM-BC: Gingival Margin to Bone Crest 
Abrahamsson et al. compared the peri-implant dimensions of implants placed in one or 
two stages, and both approaches showed no statistically significant difference.20 
However, it was found that a certain degree of width of the peri-implant mucosa would 
be needed for stability; otherwise, bone resorption could occur. In thin tissues, the bone 
was resorbed so that proper formation of the dimensions of the peri-implant mucosa 
could occur. This finding was confirmed in Berglundh and Lindhe’s study, where the 
peri-implant connective tissue portion was dissected, leaving a thin soft tissue, which 
resulted in a statistically significant bone remodeling to accommodate the normal peri-
implant mucosal dimensions.21 Additionally, a 6–8-week time frame was needed for the 





The two-stage implant placement was the proposed treatment of choice to limit the risks 
of fibro-encapsulation and microbiological complications.30 Hermann et al. compared 
one-piece and two-piece implants with different locations of the smooth and the rough 
surfaces of the implants. The peri-implant mucosal dimensions were significantly smaller 
in the one-piece implants and more comparable with those of teeth than the two-piece 
implants. Additionally, the two-piece implants were associated with a more apical 
position of the gingival margin due to bone loss.29 However, a literature review by 
Rompen et al. indicated that in animal studies, similar soft-tissue integration occurred in 
both one-piece and two-piece implants.31 
The peri-implant mucosa differs from that of teeth in orientation, vasculature, and 
content. The origin of the peri-implant mucosa is the oral epithelium, whereas in teeth, it 
originates from the reduced enamel epithelium. The peri-implant mucosa has dense 
collagen fibers that cannot insert into the implant, whereas in teeth, the fibers (Sharpey’s 
fibers) insert into the cementum. These gingival fibers around teeth are perpendicular to 
the tooth, but in the peri-implant mucosa, they are parallel to the implant and run their 
course from the periosteum of the bone to the gingival complex.18, 19  
The peri-implant mucosa also has significantly less fibroblasts and is significantly less 
vascularized in the connective tissue portion compared with teeth. The reduced 
vasculature could be attributed to the origin of the blood vessels. Teeth have two sources 
of vessels (the supraperiosteal and the periodontal ligaments), while in implants, the 
blood vessels originate from the periosteum of the bone.22 In theory, the amount of blood 
supply can affect the tissue turnover rate that can occur around implants, where in teeth, 




tissue with a low turnover rate. However, a study by Moon et al. showed that despite the 
low fibroblast amount and vascularity, when the section closest to the implant was 
examined, more fibroblasts were concentrated in this area. The conclusion was that 
although the outer layer had significantly less cells and more collagen, the inner area had 
a significantly rich area of fibroblasts. Thus, the peri-implant mucosal border closest to 
the implant has a high turnover rate, which is important in the maintenance of the seal 
and the stability of the implant.19 This finding was confirmed in a study by Abrahamsson 
et al., where the inner zone had 30–33% fibroblasts, whereas the outer zone had 10–11% 
fibroblasts.27 
1.3.1 Morphogenesis of the peri-implant mucosa in relation to different abutment  
materials used in animal studies 
Numerous types of abutment materials are available, but the main ones used are zirconia 
and titanium. Most of the studies on different abutment materials were conducted on 
animals, as shown in Table 1.4. A study by Abrahamsson et al. showed that a proper 
connective tissue and junctional epithelium were formed around healing abutments made 
of zirconia or titanium, whereas in gold alloy or porcelain, no proper attachment was 
observed, resulting in recession and marginal bone loss. In the latter materials, the 
attachment occurred on the implant surface; thus, the abutment-implant connection was 
exposed. The hypothesis is that it is either due to the variation in the materials’ 
adhesiveness or corrosion resistance. As such, ceramic and titanium are more corrosion 
resistant than gold alloy.25 However, in a more recent study, Abrahamsson and 
Cardaropoli32 compared gold alloy and titanium surface abutments and found no 




authors concluded that the fibroblasts’ adherence to smooth metallic surfaces was 
adequate regardless of the materials used. The change in the results compared with those 
of the previous study could be due to the methodological differences and the different 
brands of implants used, although the bone-to-implant contact in the different materials 
of the implants used was better in the titanium implants.32  
Table 1. 4 Effect of different materials on peri-implant mucosal dimensions 
Study Abutment materials  Findings 
Abrahamsson et al. 
25 
Zirconia, titanium, gold alloy, 
and porcelain abutments 
Bone loss and apical migration of soft tissue 
in gold and porcelain abutments  
Proper peri-implant mucosal dimensions in 
zirconia and titanium abutments 
Abrahamsson et al. 
32 
Titanium or gold abutments 
with four different 
combinations at different levels 
of the implant 
No statistically significant difference 
between the groups 
Welander et al. 33 Titanium, ZrO2, and AuPt-alloy 
abutments 
Apical migration of the junctional epithelium 
and marginal bone loss around the AuPt-
alloy abutments compared with the other two 
Zr: Zirconia; Au:Gold; Pt:Platinum; O:Oxygen 
Welander et al. conducted a study that favored zirconia and titanium healing abutments. 
They compared healing abutments made of titanium with those made of AuPt-alloy and 
ZrO2. After five months, the peri-implant mucosal dimensions remained stable for the 
ZrO2 and the titanium healing abutments, whereas in the AuPt-alloy group, an apical shift 
of the junctional epithelium and marginal bone loss occurred. Additionally, the AuPt-
alloy abutments had lower amounts of fibroblasts and collagen fibers and more 
leucocytes.33 
A review article by Rompen et al. stated: 
... titanium is the only material that has proven is biocompatibility towards the soft 




for zirconium and aluminium oxide; animal studies have shown that dental 
porcelain or gold isless biocompatible and should be avoided. Materials such as 
resins and composites should not be recommended up to now; the surface of the 
core material can be contaminated, altering the composition of the interface.31 
1.3.2 Morphogenesis of the peri-implant mucosa in relation to different surface 
topography used in animal studies 
There are conflicting results on how the different topographies of abutments affect the 
peri-implant mucosa, with some studies favoring rougher surfaces for soft-tissue 
attachment but indicating that more plaque accumulation and inflammation occur as well. 
Abrahamsson et al. compared smooth surface abutments with a dual thermal acid-etched 
surface and found no significant difference in attachment between the two in both 
quantitative and qualitative aspects.27 However, a study by Cochran et al. found that 
sandblasting and acid etching (SLActive) implants had significantly more collagen 
organization than the machine surface and smaller peri-implant mucosal dimensions. 
These longer peri-implant mucosal dimensions were due to the difference in the 
junctional epithelium dimension, not the connective tissue dimension. Additionally, a 
slight bone loss occurred around the machine-surfaced collar, whereas the SLActive 
implants had a slight bone gain. The authors concluded that the rough surface was 
osteoconductive for bone formation and had more mature soft-tissue formation. Implants 
and abutments with a roughened surface have been associated with increased plaque 




A literature review by Rompen et al. indicated that in in-vitro and in-vivo studies, surface 
roughness could have early effects on the epithelial and the connective tissue cells’ 
attachment, orientation, proliferation, and metabolism. Additionally, the rough surfaces 
could theoretically improve the initial stability and prevent the epithelial apical migration. 
Lastly, the epithelial cell adhesion was lower compared with that of the machine-surfaced 
abutment.31 
1.3.3 Morphogenesis of the peri-implant mucosa in human studies 
Human studies on the peri-implant mucosal dimensions showed a similar trend to that 
found in animal studies (Table 1.5) but could vary due to methodological differences, 
considering the nature of the designs in human studies. Tomasi et al. conducted a study 
using a special fabricated abutment to be able to conduct a biopsy on the soft tissue 
around the healing abutment in 21 patients. The peri-implant soft tissue was assessed in 
the 2-, 4-, 8-, and 12-week healing periods. The peri-implant mucosal dimensions were 
found to be similar to those in the animal studies (Table 1.5) and took approximately 8–
12 weeks for complete healing of the junctional epithelium and the maturation of the 
connective tissue.34 
Table 1. 5 Peri-implant mucosal dimensions in human studies 







Tomasi et al. 34 2 1.1 3.1 One-stage/bone-level 
implant 
12  
Schwarz et al. 35 1.88–1.96 0.43–0.55 2.35–2.51 One-stage/bone-level 
implant 
8  





1.4–2.9 N/A N/A One-stage/tissue-level 
mini implant 
8  




Schwarz et al. also showed similar peri-implant mucosal dimensions for hydrophobic 
machine-surfaced and hydrophilic acid-etched titanium and zirconia abutments. There 
was more perpendicular collagen fiber orientation on the hydrophilic abutments in 
contrast to the denser collagen and the parallel hydrophobic healing abutments. This 
difference may indicate a better peri-implant mucosal seal when using hydrophilic 
healing abutments, but how this reflects on the clinical relevance needs to be further 
examined.35 
Glauser et al. compared the healing of soft tissue in mini implants with 3 different surface 
topographies in 5 patients receiving a total of 12 mini implants. This process was done as 
a one-stage approach as it was a tissue-level implant. The different surface topographies 
were machine-surfaced, oxidized-layer, and acid-etched types. In contrast to the previous 
studies, these implants were harvested with both soft and hard tissues. The machine-
surface implants had a much greater junctional epithelium length compared with the other 
two surface topographies, as indicated by the large range listed in Table 1.5. The machine 
surface also had a smaller connective tissue length compared with the other two surface 
topographies. The surface topographies of the oxidized-layer and the acid-etched types 
showed peri-implant mucosal dimensions similar to those found in the animal studies, 
whereas those of the machine-surfaced type varied. In all sections, there was no 
perpendicular attachment of collagen fibers to the implant surface, differing from the 
result of the previously mentioned study but consistent with those of the animal studies. 
Most fibers were in a parallel direction or ran circumferentially. Additionally, connective 
tissue formed an avascular, thin, and collagen-rich scar tissue, such as around the implant 




or acid-etched surfaces due to the longer connective tissue and the shorter junctional 
epithelium compared with the machine surface. The possible explanation is that more 
surface irregularities can have a conductive effect on soft-tissue adhesion, inhibiting the 
apical migration of the junctional epithelium.36 This finding differed from those of other 
studies, which indicated that tissue-level implants, not surface topographies, affected the 
lengths of the junctional epithelium and the connective tissue. A later study found similar 
results, where the junctional epithelium was much larger than acid and oxidized healing 
abutment surfaces. However, oxidized and porous surfaces showed perpendicular fiber 
attachment compared with the parallel attachment on the smooth machine surface, which 
was somewhat controversial as most animal and human studies indicated no such 
findings.37 
1.3.4 Effect of implant loading timing on the morphogenesis of the peri-implant 
mucosa and implant success  
Brånemark developed the initial load-timing protocol of a three-month healing period for 
mandibular implants and a six-month healing period for maxillary implants. That 
protocol was proposed to minimize the chances of micromotion for an implant during the 
process where it would become osseointegrated with the bone.38 The concept of not 
loading implants was challenged in numerous studies. Ledermann et al. immediately 
loaded three to four implants in overdentures, with a reported 91.2% survival rate over 
six years.39, 40   
The peri-implant mucosal dimensions in immediate and conventional loads were found to 




not affected by the loading time, and Hermann et al. reported that the peri-implant 
mucosal dimensions were not significantly different between immediate and conventional 
loading of the implant.41, 42 A systematic review by Glauser et al. concluded that soft-
tissue healing around immediate implants was comparable to that of conventional 
loading, with little evidence of the effect of the loading time on the peri-implant mucosal 
dimensions.43 
Szmukler-Moncler’s literature review concluded that with careful and strict patient 
selection, successful premature loading could be achieved.44 A systematic review by 
Esposito et al. showed a 0.1-mm difference in bone loss when immediate implants were 
compared with conventional loading, which was too small to be of clinical significance. 
Overall, there was no clinically important difference in prosthesis failure, implant failure, 
or bone loss associated with the different loading times. The most important prerequisite 
for immediate and/or early implant loading was a high value of at least 35 Ncm of the 
insertion torque. Additionally, the systematic review compared two concepts—immediate 
occlusal loading and immediate nonocclusal loading—with no significant differences 
between the two.45 
1.4. Implant Microgap 
In the early time frame of implant dentistry, a 1.5-mm crestal bone loss around an 
implant during the first year after restoration was considered part of the success criteria 
because the external hex connection was the implant-abutment connection that was 
mostly used.6 This idea was later challenged in a study by Hermann et al., who compared 




bone loss for the two-stage implants, whereas in the tissue-level implants, minimal bone 
loss occurred. Moving this interface apically in two-stage implants also led to 1.5–2 mm 
of bone loss.29,46 Buser et al. reinforced this idea of minimal bone loss around tissue-level 
implants in a human clinical study spanning over eight years.47 The bone loss could not 
be attributed to the occlusion or the placement of an implant because it only occurred 
when the implant-abutment interface was changed. 
One reason for bone loss occurring in the implant-abutment interface is the presence of 
bacteria, in which the body establishes a safe distance from this inflammatory front.48 To 
minimize this presence, reducing the microgap distance in the implant-abutment interface 
was attempted, but this resulted in no difference in the amount of bone loss.49, 50 
Another reason for bone loss is the micromotion that occurs in the implant-abutment 
interface. This phenomenon was demonstrated in a study by King et al., where the 
healing abutment was welded with the implant in one group, while it was not welded in 
the other group, but the same microgap distance was maintained. Since the welding 
eliminated the micromotion, bone loss was significantly reduced. Micromotion is 
believed to result in bone loss for two reasons: first, the micromotion can have a micro-
pumping effect on bacteria and their by-products; second, it can compromise the 
attachment and the stability of the tissues around the implant neck.50,51 Furthermore, there 
is a synergistic effect between the microgap and the micromotion—where the microgap 
exacerbates the microleakage and the micromotion, which in turn further increases the 




A systematic review by Vouros et al. compared bone loss in tissue-level and bone-level 
implants. The mean marginal bone loss in the meta-analysis revealed a difference of -
0.03–0.13mm, which was not statistically significant. The authors concluded that over a 
three-year period, there was no statistically significant difference in bone loss between 
the two types of implants. However, many of the bone-level implants in the study were 
platform switched, which had less marginal bone loss than the platform-matched ones.52 
1.4.1 One-abutment, one-time concept 
Abutment disconnection/reconnection is associated with marginal bone loss on the 
implant-abutment seal due to the apical migration of the peri-implant mucosa to protect 
the bone.21, 53 Thus, the one-abutment, one-time concept, which means placing the final 
abutment simultaneously with the implant, is used for impression and implant restoration 
to minimize the effects on the implant-abutment seal.  
Several animal studies investigated the effects of repeated disconnection and 
reconnection of healing abutments. Abrahamsson et al. evaluated these effects on 
external hex implants and found a 0.7-mm apical shift of the implant-abutment seal when 
the abutment was disconnected five times.53 The same group of researchers conducted 
another study and found that when the disconnection and the reconnection were done 
only twice, there were no statistically significant differences between the control group27 
Furthermore, even implants with a platform-switched design showed bone loss when the 
amounts of disconnections/reconnections were increased although to a lesser extent. The 
authors emphasized the need for reducing the number of disconnections/reconnections of 




the first to show that definitive abutments did not affect the long-term prognosis for 
implants. 55, 56 
Several systematic reviews were conducted on abutment disconnection/reconnection 
and/or the one-abutment, one-time concept (Table 1.6). A systematic review and meta-
analysis by Koutouzis et al. found a statistically significant weighted mean difference of 
0.19 mm more bone loss during abutment disconnection/reconnection and concluded that 
current protocols should be reviewed to try minimizing this effect.57 Wang et al. also 
reported that definitive abutments provided less marginal bone loss and soft-tissue 
recession.58 Atieh et al. noted a statistically significant difference in marginal bone loss; 
when the disconnections/reconnections were ≤ 2, there was a 0.18-mm less marginal 
bone loss in the definitive abutment group, and when the disconnections/reconnections 
were >2, there was a 0.2-mm less marginal bone loss in the definitive abutment group.59 
Lastly, Tallarico et al. observed a marginal bone loss difference of 0.279 mm between the 
definitive abutments and disconnection/reconnection groups, favoring the definitive 
abutments. Furthermore, a greater buccal recession of 0.198 mm occurred in the 
disconnection/reconnection abutment group.60 A problem mentioned in these systematic 
reviews is that several factors may contribute to the bone loss other than the abutment 
disconnection/reconnection. Therefore, these results should be taken with caution, and 
more studies are needed to assess the clinical significance of the marginal bone loss since 






Table 1. 6 Systematic reviews on abutment disconnection and reconnection 




Marginal bone loss mean 
difference 
Conclusion 









“Abutment disconnection and 
reconnection significantly 
affected peri-implant marginal 
bone levels. This information 
paves the way to revisit current 
restorative protocols at the 
restorative treatment planning 
stage to prevent incipient 
marginal bone loss.” 
Wang et al. 58 6 studies 
411 implants 
Fixed-effect model in mean 
values: 
0.41 mm, 6 months 
1.51 mm, 12 months 
2.47 mm, 3 years 
“One-time abutment is superior 
to repeated abutment for 
platform-switched implant 
because of less bone resorption 
and soft tissue shifts in [the] 
former.” 
Atieh et al. 59 7 studies 
363 implants 
0.20 mm > 2 
disconnections/reconnections 
 
0.18 mm ≤ 2 
disconnections/reconnections 
“Definitive abutments appear to 
be a viable alternative to 
healing/provisional abutments at 
[the] time of implant 
placement.” 
Tallarico et al. 60 14 studies 
994 implants 
(less used for 
meta-analysis) 
0.279 mm  “Repeated abutment 
disconnections and 
reconnections considerably 
increased marginal bone loss and 
buccal recession.” 
 
The problem with using stock abutments as definitive ones is that they do not provide the 
proper support, the emergence profile, and the contour of a restoration. The margins of 
stock abutments are not controlled and are dictated by the depth of the implant 
placement, resulting in deep margins and limiting access to cement removal.61 
Additionally, the deeper the margin of these stock abutments, the greater the amount of 
the expected excess cement.62 Unremoved excess cement can be a major concern 
associated with peri-implant mucositis and peri-implantitis, and Wilson’s study found 




With custom abutments, the architecture to shape the gingiva can be dictated, providing 
control of the emergence profile and establishing a more coronal gingival margin. To 
place the abutment simultaneously with the implant, preoperative digital planning and 
restorative planning are needed. Typically, this process requires hard- and soft-tissue 
imaging, using a cone beam computed tomography (CBCT) scan and either an 
impression or an intraoral scan. Merging these two files provides a full image of a 
patient’s hard and soft tissues, which enables the planning of the three-dimensional 
position of the implant, the location of the gingival margin, and the architecture of the 
custom abutment. One problem that arises when planning the custom abutment before 
surgery is that the mucosal margin cannot be predicted because recession does occur. 
Numerous studies have shown that 0.6–1.5 mm of recession can occur, and depending on 
the patient factors—such as the location of the implant, the patient biotype, the smile line, 
and so on—the clinician needs to plan where the gingival margin should be located. Deep 
margins can lead to a similar complication in stock abutments where the cement is 
difficult to remove, whereas the coronal margin will result in an unaesthetic outcome.64-69 
1.5.  Platform switching 
The concept of platform switching involves the implant-abutment interface where the 
healing abutment is smaller in diameter than the implant, thereby creating a platform on 
the implant coronally. Historically, when wide-diameter implants were used, a situation 
was created without matching size components, so a smaller diameter abutment was used. 
Early studies in 2005 found favorable soft- and hard-tissue healing around these 




Several theories exist on why less bone loss occurs in platform-switched implants. One 
theory is that due to the horizontal displacement of the interface, there is an increased 
distance between the bone and the bacteria that can penetrate the interface. A study by 
Luongo et al. found that an inflammatory infiltrate was localized approximately 0.35 mm 
above the implant-abutment interphase but did not reach the bone, which could explain 
the minimal bone loss. They also observed that the stress concentration was more on the 
implant abutment/screw than the bone; despite the minimal difference, it could have an 
effect.72 Another theory is that connective tissue occupies the space in the horizontal 
displacement of the implant-abutment interface, whereas in the butt joint, the junctional 
epithelium is usually located apically to the implant-abutment interface. A study on 
platform-switched implants conducted by Baffone et al. indicated that the most important 
finding was the presence of connective tissue around the implant-abutment interphase, 
which was not observed in matching implant abutments.73 The mismatch between the 
implant-abutment interface could also reduce the bacterial load and/or increase the 
stability by means of a Morse taper internal connection.74  
A study by Trammell et al. showed similar peri-implant mucosal dimensions in platform-
switched and platform-matched implants, 1.53 mm and 1.57 mm, respectively.75 
However, less bone loss occurred in the platform-switched implants in this study. This 
finding was confirmed in the study of Cochran et al., where 12 platform-switched 
implants were used in dogs and loaded for 6 months. The peri-implant mucosal 
dimensions used in this study were 1.80–2 mm when the implant-abutment interphase 
was placed at or above the bone crest compared with 2.3–2.6 mm when placed apical to 




and 0.38 mm, respectively. This range of bone loss was five to six times less than that of 
conventional external hex matching connections.76 In their clinical human study, Fickl et 
al. showed that after one year of function, platform-switched implants had a mean bone 
loss of 0.39 mm compared with 1 mm in the nonplatform-switched implants.77 
Several systematic reviews and meta-analyses have established less bone loss in 
platform-switched implants. 78-83The most recent systematic review and meta-analysis by 
Hsu et al. was the first that observed not only hard-tissue but also soft-tissue differences 
in platform-switched implants. For hard tissue, crestal bone loss was found to be 0.35 
mm in the first year and remained less than 0.5 mm for 5 years. There was a significant 
reduction in the probing depth around platform-switched implants. Slight losses of the 
midfacial tissue height and the keratinized mucosa were also observed in the platform-
switched implants. However, the authors mentioned that soft-tissue thickness could have 
played a role, and further studies on this issue would be needed. The location of the 
implant-abutment interphase also played a role in the amount of the observed vertical 
bone loss.84 Several systematic reviews and meta-analyses revealed similar results in 
terms of improved marginal bone levels in platform-switched implants (see Table 1.7). 
The degree of the mismatch also affected the mean marginal bone levels, with an 
increased mismatch leading to less marginal bone loss. A systematic review and meta-
analysis by Valles et al. compared subcrestal and equicrestal positions on the peri-implant 
hard and soft tissues in platform-switched implants. The peri-implant mucosal dimension 
was larger when the implants were placed in a subcrestal position, which was due to an 
increase (mean = 0.39 mm) in the junctional epithelium. However, no difference in the 




implants that were placed in a subcrestal position exhibited greater marginal bone losses 
of 0.18 mm in human studies and 0.45 mm in animal studies. The subcrestal placement of 
the platform-switched implants also resulted in a more coronal position of the bone. The 
authors concluded that the implant-abutment interphase location affected the amount of 
bone loss that occurred.85 
Table 1. 7 Summary of systematic reviews on platform switching and crestal bone loss 









Degree of implant switching Conclusion 
Santiago et 






N/A “Platform-switching implants 
showed greater relevant bone 
preservation when compared to 
regular platform implants.” 
Chrcanovic 




-0.29  “There is an increase of the 
mean difference of marginal 
bone loss between the 
approaches with increasing 
follow-up time and with 
increase of the mismatch 
between the implant platform 
and the abutment.” 
“Significantly less marginal bone 
loss at implants with platform 




22 studies  
2,235 
implants 
-0.52  N/A “Results favor the platform 
switching technique to prevent or 
minimize peri-implant marginal 
bone loss, compared to implants 
with platform matching” 
Herekar et 




-0.34  “A greater mismatch between 
the diameters of implant and 
abutment leads to better bone 
preservation.” 
“Platform switching holds 
promise as a simple, functional, 
and predictable technique for 
preserving peri-implant crestal 
bone.” 
Annibali et 




95% CI:  
-0.86 to  
-0.24; 
p = 0.0006 
“Limiting marginal bone loss 
is more evident with 
increasing the extent of 
implant-abutment 
mismatching.” 
“The present meta-analysis 
confirmed the effectiveness of 
platform-switching techniques in 
limiting marginal bone resorption 
around dental implants.” 




95% CI:  
-0.55 to  
-0.20; 
p < 0.0001 
“Additional improvement in 
the marginal bone levels 
around dental implants may 
also be obtained with a 
greater degree of shifting.” 
“Platform switching can be 
considered a desirable 
morphologic feature that may 
prevent horizontal saucerization 
and preserve the vertical crestal 
bone.” 




1.6. Abutment macro-design effect on peri-implant hard and soft tissue 
A change in the macro design of the abutment can impact the bone levels and the soft-
tissue levels and lead to excess cement, which is difficult to remove. The two main types 
of macro designs used are the concave and the convex abutments. Abutment macro 
designs were evaluated in several animal studies, with varying results. Lopez et al. found 
that anatomically wider abutments had less marginal bone loss and more connective 
tissue attachment than concave straight abutments, whereas Finelle et al. reported more 
bone loss in wider abutments.86, 87 The differences in these two studies were most likely 
due to different implant placement timings. In immediate implants, the wider healing 
abutment prevents the gingival architecture from collapsing and protects the soft and the 
hard tissues, whereas in healed ridges, the gingival flap reacts more favorably to narrow 
healing abutments in order to maintain the soft tissue.  
One feature of abutment macro designs—the abutment contour—is divided into two 
portions. One portion, called the critical contour, corresponds 1 mm apically to the level 
of the peri-implant mucosa. The other portion, called the subcritical contour, extends 
apically to the critical contour up to the implant junction. An alteration of the subcritical 
contour to a convex macro design was reported to relocate the peri-implant coronally, 
thus enhancing the aesthetics.88 A study by Huh et al. found that the concave machine 
transmucosal design exhibited less bone loss and better connective tissue attachment 
compared with the straight machine-profiled implants because of the increased space for 
connective tissue healing. Since this was an animal study with a 16-week follow-up, any 




Kim et al. examined the influence of three transmucosal designs of one-piece implants 
and found that a concave transmucosal design with a microgrooved surface had a longer 
connective tissue attachment and less bone loss compared with the rough or the straight 
abutments. The peri-implant mucosal dimensions for the concave machine grooved 
design were 1.99 mm for the junctional epithelium and 0.92 mm for the connective 
tissue, whereas the other two designs (flared and straight) had a significantly greater 
junctional epithelium length and a significantly less connective tissue length.90 
In a randomized controlled trial, Patil et al. compared curved and straight abutments. 
They found that the two groups had no statistically significant difference in marginal 
bone levels, pink aesthetic scores, and probing depths.91 Axiotis et al. conducted a 
retrospective study on one-piece implants with a concave neck and found 0.57 mm of 
bone loss after five years, which they attributed to the increase in the soft-tissue thickness 
from the design of the concave neck.92 
In a case series study conducted by Rompen et al., the abutments with a concave 
subcritical contour demonstrated stable peri-implant mucosa levels with no recession > 
0.5 mm. However, their study had no control group with other types of abutment macro 
designs.93  
Sancho-Puchades et al. compared concave and convex abutments in-vitro and how they 
would affect the removal of cement in the epigingival location and the 1.5-mm and the 
3.0-mm subgingival locations. When all these areas were grouped, the concave abutments 
retained significantly more cement than the convex abutments. However, when the 




excess cements in the concave and the convex abutments except in two locations—at the 
distal margin in the epigingival group and at the buccal margin of the 3-mm subgingival 
placement. The authors also found that the periapical radiographs did not identify all the 
cements, and the deeper the crown-abutment margin, the more excess cement was left, 
and the more difficult it was to remove this cement. The authors concluded that although 
for aesthetic purposes, they could not use a supragingival placement of the margins, they 
would not recommend having the crown-abutment margin located 1.5 mm apically, and 
even a 1-mm apical margin resulted in cement remnants.62 
Due to the different designs used in the cited studies, little evidence is provided for the 
use of a two-piece implant and how the abutment contour can affect the peri-implant 
mucosa. As such, the present research aims to assess the difference in two-piece implants 
with concave and convex definitive abutments. 
1.7. Accuracy of CBCT imaging 
The accuracy of CBCT implants is important for the presurgical analysis of implant 
placement. One of the main limitations in CBCT scans is the presence of artifacts, for 
example, when trying to assess the bone around an implant. For implant treatment 
planning, a systematic review by Fokas et al. indicated high levels of accuracy and 
reliability for bony linear measurement, but either overestimation or underestimation can 
occur. The factors that affect the accuracy are the patient motion, the metallic artifact, 
device-specific exposure parameters, the software used, and manual/automated 
procedures. The authors also warned that a 2-mm margin should be used when placing 




Razavi et al. assessed the accuracy of cortical bone thickness at varying distances of 3, 6, 
and 9 mm from an implant. Two CBCT scanners were used (i-CAT NG and Accuitomo 
3D60 FPD) and compared with the gold standard of measurement using a light 
microscope. The examiners found that the measurement accuracy was significantly 
underestimated in the i-CAT NG, with mean percentage errors of 68% at 3 mm, 28% at 6 
mm, and 18% at 9 mm. The Accuitomo 3D60 FPD measurements were better, except 
when the bone thickness was < 0.8 mm. The mean percentage errors were 23% at 3 mm, 
5% at 6 mm, and 6% at 9 mm. The authors concluded that the Accuitomo 3D60 FPD 
provided a better resolution in the thin bone areas compared with the i-CAT NG.95  
Wang et al. used the PaX Duo3D CBCT system and found that the mean difference 
between the histological section and the CBCT scan was 0.22 mm in the buccal bone. 
The authors concluded that this system had an approximately 0.5-mm accuracy in 
assessing the buccal bone thickness.96 In an in-vitro study, Naitoh et al. examined 5 
different thicknesses of the buccal bone in relation to the aluminum steps and found that 
at a 0.6-mm buccal bone thickness with a 51–102-mm diameter, an exposure volume 
>50% was observed. . Another study showed that a <0.72-mm buccal bone thickness in 
the horizontal dimension was not accurately measured using the i-CAT NG, and the 
thinner the bone, the more its thickness was underestimated.97  
Liedke et al. assessed the accuracy of detecting the buccal bone thickness adjacent to the 
implants. They found high sensitivity and low specificity in the buccal bone detection. 
Additionally, the CBCT measurements overestimated the thickness in all settings 
compared with the actual measurements. The mean buccal bone measurements using the 




authors concluded that although the buccal bone thickness was overestimated in the 
CBCT measurements, it lay mostly within 0.5 mm of the actual buccal bone thickness.98 
Different settings and software’s can affect the accuracy of CBCT’s, but the presence of a 
metallic object can distort the measurements and as such one needs to be aware that these 
numbers might not reflect the true value, although as shown in most studies the 
difference is generally less than 1mm. 
1.7.1 CBCT Peri-implant bone evaluation 
The importance of an intact buccal bone has been emphasized for both esthetic and 
functional success of an implant. Re-entry of the area surgically after implant placement 
to measure the buccal bone can be a risk to the patient as well as unethical. As such, the 
use of CBCT scan to measure peri-implant bone has been evaluated and done in 
numerous studies. A pilot study was done by Vera et al. to evaluate the use of CBCT 
scans to measure the peri-implant bone changes. The authors concluded that buccal bone 
and alterations in the buccal bone can be seen in CBCT when it is 0.5 to 1.5 mm in 
buccolingual dimension next to the implant. The authors found a 1.12mm of vertical bone 
loss and 0.62 of horizontal bone loss 1mm below the apical crest at the 1-year 
evaluation.99  Cho et al. evaluated the buccal bone changes in 26 implants with the use of 
CBCT, with only 4 receiving immediate implants in the anterior maxilla. The authors 
found a mean vertical resorption of 1.32mm in the 3 years CBCT evaluation.100 A study 
by Koutouzis et al. evaluated the marginal bone levels around platform switched implants 
placed at different positions related to the alveolar crest in a CBCT scan after 10 years. 
The amount of buccal bone remodeling occurred less when the implants were placed 




thickness had a negative correlation to buccal bone remodeling when implants were 
placed subcrestal. 101 
In immediate implant placement, Kuchler et al. reported a vertical bone loss of 1.7mm 
with 24% of the implant showing no visible facial bone after 10 years in the CBCT 
assessment.102 Another study by Benic et al. showed a vertical bone loss of 3.1mm and 
35.7% of absence of buccal bone after 5 years in the CBCT evaluation. 103 Chappuis et al. 
examined the amount of bone loss associated with early implant placement over 10 years. 
The authors found that after GBR with early implant placement, a vertical bone gain of 
3.16mm and the buccal wall thickness increased by 1.67mm measured by the CBCT scan 
after 10 years. The authors concluded that early implant placement technique is more 
predictable for management of the anterior maxillary esthetic area compared to 
immediate implants, due to the complication risk of loss of buccal bone and risk of 
mucosal recession. 104 The reason for that is that during immediate implant placement, 
the alveolar bone resorption that is normally seen during extraction will occur regardless 
of implant placement. Whereas in early implant placement there are several theories of 
why this technique works. First, biologically we after 8 weeks we have less activity of 
inflammatory mediators and increased activity of bone forming proteins and endothelial 
cells. Second, the morphology of the socket after 8 weeks of healing provides a favorable 
2 wall defect which is more stable for bone grafting. Lastly, the autogenous bone used in 
this technique provides an increased and accelerated new bone formation. 
A study by Benic et al. evaluated not only the peri-implant bone, but the peri-implant 
mucosal dimensions on CBCT. This was done by applying a composite layer around the 




implants showed no detectable buccal bone and more apical location of the mucosal 
margin, however, the apical position of the margin only amounted to 1mm difference 
compared to the implants with intact facial bone. The mean thickness of the peri-implant 
mucosa 1mm apical to the gingival margin was 1.5mm irrespective of whether the buccal 


















2. Materials and Methods 
The protocol for the study was approved by the Institutional Review Board (IRB) of 
Nova Southeastern University and followed the tenets of the Declaration of Helsinki. 
Informed consent was obtained from the subjects after explanation of the nature and 
possible consequences of the study. 
2.1. Research Plan 
This trial was designed as a randomized controlled clinical study in which two groups of 
fourteen partially edentulous patients had one implant placed in the maxillary premolar 
region as part of their treatment. Implant placement and abutment design were planned 
with a computer software for guided implant treatment (SIMPLANT). The surgical 
implant placement was 3-4 mm below the buccal aspect of the future crown margin. 
Virtually designed, permanent CAD-CAM fabricated abutments (ATLANTIS, 
DENTSPLY) with different configuration of the subcritical contour (emergence shape) 
were connected to the implants and temporary crowns were delivered.  
Implants assigned to concave (CV Group) received permanent abutments with a concave 
configuration of the subcritical contour (emergence shape). Implants assigned to convex 
(CX Group) group received permanent abutments with a convex configuration of the 
subcritical contour (emergence shape). Patients had the final implant restoration 3 months 
following implant installation. A block randomization sequence was utilized to provide 
equal distribution of subjects between the two groups. Treatment assignments were 
performed at the planning stage of treatment. Randomization envelops were used and 




software and immediately prior to ordering the implant abutment. The study was double 
masked, with both the examiner and subjects not being not aware of the allocated 
treatment. The null hypothesis is that the abutment macro design has no effect on peri-
implant tissue and bone level dimension changes from the time of the implant installation 
to the 1 year follow up. 
2.2. Abutment Design 
The abutments of both groups were designed with the aid of an implant treatment 
planning software (SIMPLANT), in conjunction with planning of the implant placement, 
and was produced by CAD-CAM technology (ATLANTIS, DENTSPLY) according to 
patient needs. For both groups the abutments were designed based on the individual 
topography of the recipient site in terms of soft tissues and relationships with adjacent 
teeth. Care was taken to position the implant platform 3-4 mm below the buccal aspect of 
the future crown margin. All abutments were selected in titanium and had the buccal 
margin planned 1 mm submucosally, the interproximal margins 0.75 mm submucosally 
and the lingual margin 0.5mm submucosally. For patients in the CV Group, the 
abutments were designed with a concave configuration between the abutment margin and 
the Implant-Abutment Interface (IAI). For patients in the CX Group, the abutments were 
designed with a convex configuration between the abutment margin and the IAI.  
2.3. Inclusion and exclusion criteria 
General Inclusion criteria: 




• Absence of relevant medical conditions 
• Availability for 12-month follow-up 
General Exclusion criteria: 
• Pregnancy at the screening visit 
• Smoking more than 10 cig/day 
Specific Inclusion criteria: 
• One missing tooth in the maxillary premolar region 
• Presence of two adjacent teeth at the implant site 
• Absence of periodontal disease 
• Healed osseous architecture enough to receive an implant with a diameter of at 
least 3.5 mm and a sufficient amount of bone for placing implants with a length 
of at least 9 mm 
Specific Exclusion criteria: 
• Adjacent implants 
• Presence of periapical radiolucency at the adjacent teeth 
• Missing adjacent teeth 
2.4. Study procedures and visits 
Each subject was seen for a total of 6 appointments; Screening, implant placement (T0), 
suture removal, final crown delivery (T1) and a 1 year follow up from the date of implant 




July/2018. All treatment was done in Periodontics clinic at Nova Southeastern 
University.  
First Visit: Screening 
Screening of patients was performed to determine if patients were eligible to participate 
in the study. In the screening visit medical history was reviewed for each patient and if 
the patient fulfilled the general inclusion criteria a dental clinical exam was performed to 
ensure that patients had an edentulous space at the maxillary premolar region, with two 
adjacent teeth. For patients that fulfilled this criterion a full mouth periodontal exam was 
performed to confirm periodontal status and a periapical radiograph was taken to ensure 
adequate bone height for implant therapy and the absence of periapical pathology at 
adjacent teeth. Informed consent was obtained from all eligible patients and the study 
procedures were explained to them. For eligible patients, a polyvinyl siloxane material, a 
bite registration and a cone beam computed tomography (CBCT) was taken for planning 
the placement of the dental implant, designing the abutment, fabricating the surgical 
guide, abutment and the provisional restoration.  
Second Visit, Day 0 (T0): Implant Placement 
1. Mucosal thickness measurement 
2. Bone measurements 
3. Peri-implant bone measurements 
4. First peri-implant soft tissue examination 






The surgical treatment was performed under local anaesthesia and according to 
manufacturer’s manual. The implants (Ankylos, Dentsply Sirona Implants, Mölndal, 
Sweden) used had a diameter of 3.5mm and lengths varying from 9 mm to 14 mm. 
Sulcular incisions were made at the teeth facing the edentulous area and these incisions 
were connected by a crestal incision placed on the edentulous area. A buccal full-
thickness flap was reflected initially, while the lingual flap was not elevated to ensure 
direct visibility. Vertical soft tissue thickness was measured with a periodontal probe 
(PCP 15) to the nearest half mm (see mucosal thickness measurement). After the 
measurement the lingual flap was raised to completely expose the recipient site. The 
surgical guide (SIMPLANT SAFE GUIDE) was secured to the adjacent teeth (Fig. 2.2) 
and the osteotomies were drilled according to the protocol of the manufacturer 
(ANKYLOS, DENTSPLY) Prior to implant installation, the thickness of buccal and 
lingual cortical plates was measured 1mm apical to the crest of the ridge (see 
intrasurgical bone measurements). The implant was installed with the implant platform 3-
4mm below the future crown margin (Fig. 2.5). Following implant installation peri-
implant bone measurements were performed (see peri-implant bone measurements).  
In case that following implant installation, there was a fenestration at the apical part of 
the implant; a bone replacement graft material covered by a resorbable barrier membrane 
was utilized to correct the defect. 
For patients of the CV Group an abutment with a concave configuration between the 




methacrylate (PMMA) was delivered. For patients of CX Group an abutment with a 
convex configuration between the abutment margin and the IAI was connected to the 
implant and a milled PMMA was delivered (Fig. 2.6, 2.7). Provisional PMMA 
restorations were adjusted if needed and cemented with temporary cement. Cementation 
was performed prior to suturing in order to visualize and remove any excess cement. All 
restorations were kept out of occlusion. Following abutment placement, flaps were 
adapted and closed with interrupted sutures. 
Lab made measurement stent was fabricated using a light cured resin material (Triad, 
Dentsply). Immediately, after prosthesis placement the measurement stent was used to 
obtain the peri-implant soft tissue measurements (see peri-implant soft tissue 
examination) (Fig. 2.13).  
Each patient took 500 mg amoxicillin three times daily from the day of the implant 
surgery for seven days. Each patient rinsed with Chlorhexidine 0.12% mouthwash twice a 
day for two weeks. 
Periapical and bite-wing radiographs were taken from each study site immediately after 
the implant placement surgery.  
Third Visit, day 7-10 days: Suture removal 
Patients returned after 7-10 days for examination of implant sites to assess the healing 
progress, to remove remaining sutures, and to reinforce oral hygiene instructions. This was 
done according to the standard clinical protocols.  





2. Second peri-implant soft tissue examination 
3. Clinical photograph 
Peri-implant soft tissue examination was performed for each study site. Any exposed 
abutment margin was recorded. In case that the permanent abutment was functionally and 
aesthetically acceptable, an abutment level impression was taken in order to produce the 
final restoration. Clinical photographs were taken (Fig. 2.9). 
Fifth Visit, day 90 ± 20 days (T1): Crown delivery 
1. Third peri-implant soft tissue examination 
2. Second radiographic examination 
3. Clinical photograph  
Final restoration was delivered. Peri-implant soft tissue examination was performed for 
each study site. Periapical radiographs were taken from each study site. Clinical 
photographs were taken (Fig. 2.10). 
Visit 6 (Day 360 ±20 days (T2): One year follow up after implant placement 
1. Fourth peri-implant soft tissue examination 
2. Third radiographic examination 






Peri-implant soft tissue examination was performed for each study site. Standardized 
periapical radiographs was taken from each study site. A CBCT imaging was done but 
prior to this layer of flowable light-curing composite resin was applied onto the soft-
tissues around the implant and the adjacent teeth. The radiopaque material was used as a 
contrast for the visualization of the soft-tissues on the CBCT image. A polyvinyl siloxane 
impression was taken for a study model that will facilitate evaluation of the peri-implant 
tissues. Clinical photographs were taken (Fig 2.12). 
 





Figure 2. 2. Tooth-supported SIMPLANT guide fitted on teeth. 
 











Figure 2. 5. Subcrestal position of the implant. 
 





Figure 2. 7. CAD-CAM provisional crown. 
 





Figure 2. 9. Impression appointment. 
 





Figure 2. 11. Bitewings radiographs at the time of implant placement (left); at the time of 
final crown delivery (center); and at 1-year post (right) 
  













Mucosal thickness measurements 
Following local anaesthesia, a buccal full-thickness flap was reflected initially, while the 
lingual flap was not elevated in order to ensure direct visibility. Vertical soft tissue 
thickness was measured with a PCP 15 periodontal probe to the nearest half mm (Fig. 
2.13). 
 
Figure 2. 13. Mucosal thickness measurements. 
Bone measurements 
Subsequent to osteotomy preparation, thickness of the buccal and lingual cortical plate 
was measured at a point 1 mm apical to the crest of the ridge. All measurements were 





Peri-implant bone measurements 
Subsequent to implant installation the distance from the implant platform to the most 
coronal part of the osteotomy was measured at four sites per implant (mesial, distal, 
buccal, lingual), with a PCP15 periodontal probe to the lowest half mm. 
Radiographic examination 
Radiographic examinations were performed at T0, at T1 and T2 (Figure 4). Vertical 
bitewing radiographs were taken using a paralleling device (Dentsply Rinn, York, 
Pennsylvania , USA) and a digital imaging software system (XDR, Dental Imaging, Los 
Angeles, California, USA).  
For each implant, the radiographs were evaluated regarding the degree of subcrestal 
implant position (SP), as well as marginal bone level (MBL). The method for evaluating 
peri-implant marginal bone for subcrestally placed implants has been described 
previously (Donovan, Fetner, Koutouzis, Lundgren 2010). A line following the long axis 
of the implant was drawn at the mesial and distal aspects of each implant. The distance 
between the point that this line crossed the alveolar bone crest to the first visible bone to 
implant contact was considered as the SP. MBL was calculated as the distance between 
the implant shoulder and the first visible bone to implant contact. In situations where 
bone was seen above the implant shoulder, marginal bone level still recorded as zero. The 
radiographs were downloaded as 16-bit, JPEG files and analysed with an image 
processing system (NIH Image J, National Institutes of Health, Bethesda, Maryland, 






A clinical photograph was taken at 1:1 magnification perpendicular to the buccal surface 
of the implant using digital camera with macro lens and ring flash. A photograph was 
taken to include full representation of the adjacent premolar. 
Peri-implant soft tissue examination 
Clinical assessment of peri-implant tissue was performed including the following 
variables at four sites per implant (mesial, distal, buccal, lingual): 
• Probing depth (PD): the distance between the peri-implant margin and bottom of 
the probable pocket measured with a PCP15 periodontal probe  
• Peri-implant mucosa margin position (MP): The distance between the peri-
implant margin and the stent (Fig. 2.14) 
• Bleeding on probing (BOP): presence/absence of bleeding within 15 sec 
following pocket probing 
• Presence or absence of visible plaque 
Width of keratinized mucosa (KM) was measured at the buccal aspect of each implant. 
MP was recorded immediately after implant placement and provisional restoration 
placement (T0) , at the time of  prosthesis placement (T1) and at 1 year following implant 
installation (T2). KM was evaluated at the same time intervals. PD, BoP and presence of 






Figure 2. 14. Soft tissue measurements using lab made stent. 
CBCT Imaging 
All CBCT measurements apart from two were done on CS 3D Imaging Software. Three 
lines were drawn on the CS 3D Imaging Software for orientation purposes (Fig 2.15). 
First line was parallel to the implant (A), second line was perpendicular to the implant at 
the implant-abutment junction (B), and 3rd line was perpendicular to the implant at the 
gingival margin (C). The landmarks used to do the measurements are seen in Figure 2.15 
which were the first bone to implant contact (fBIC), implant platform (IP) and bone crest 
(BC). 
Three vertical measurements parallel to the implant were done (Fig 2.16 and Fig 2.17) 
1. Implant platform to gingival margin (IP-GM) 
2. Implant platform to bone crest (IP-BC) 




Four horizontal measurements parallel to the implant platform were done (Fig 2.16 and Fig 
2.17) 
1.  Soft tissue thickness 
a. At the level of implant platform (ST1) 
b. Directly above the bone crest (ST2) 
c. Midpoint of the BC-GM (ST3) 
2. Bone thickness (BT) 1mm apical to bone crest  
The next two measurements were done on a different program, ImageJ, since the CBCT 
software only measures in straight lines. A line was drawn on the CBCT image, which is 
used as a reference of size on the ImageJ software. 
1. Soft tissue Profile (STP) (Fig 2.16 and Fig 2.17) 
2. Soft tissue area (AREA) coronal to bone crest with the borders as follows (Fig 2.18 
and 2.19) 
a. Bone crest apically 
b. Buccal gingival contour  
c. Soft tissue profile 
Presence of bone on the buccal implant platform was assigned as either present or absent. 
If bone loss was seen on the buccal, the bone loss was measured from the implant platform 





Figure 2. 15. CBCT orientation lines and landmarks; fBIC: first bone to implant contact 






Figure 2. 16. Measurements on the concave abutment. Vertical Measurements A: IP-
GM; B: IP-BC; C: BC-GM. Horizontal measurements D: ST1; E: BT; F: ST2; G: ST3. H: 
STP. 
 
Figure 2. 17. Measurements on the convex abutment. Vertical Measurements A: IP-GM; 






Figure 2. 18. Area measurement on the concave group. 
 





2.6. Data analysis 
With an α error of 0.05, the power calculation based on the detection of 0.5 mm 
difference in mean buccal peri-implant mucosa margin position between groups with a 
standard deviation of 0.5 mm (Koutouzis, Neiva, Nonhoff, Lundgren 2013), revealed that 
14 subjects were required in each treatment group to have a power of 80%. 
For description of data mean values, standard deviations (SD) and frequencies were 
calculated. The primary outcome variable was change of buccal peri-implant mucosa 
margin position. Fisher’s exact test was used to evaluate differences in frequencies of 
plaque, bleeding on probing and pocket depth categories between treatment groups. A 
Mann-Whitney U Test used for continuous data. Vertical soft tissue thickness and buccal 
bone thickness in relation to buccal peri-implant mucosa margin position change was 
calculated and the correlation was analyzed using Pearson correlation coefficient. Soft 
tissue CBCT measurements were analyzed using Pearson correlation coefficient. A p-
value of <0.05 was considered as statistically significant. All statistical analysis was done 








3.1. Results comparing concave group and convex group 
A total of 28 patients were included in the study, however, two people were excluded 
because one had to move out and the other had an implant failure within a week. There 
were no statistically significant variations between the groups in age or the site used (Table 
3.1). Thirteen patients with thirteen implants from each group were available for analysis. 
This reduced the power of the study to 69%. 
The average age was 59.08 ± 7.3 years old and 54.62 ± 8.4 years old in the CX and CV 
Group respectively. 
Table 3. 1 Descriptive statistics of the 2 groups. 
Group Number of 
patients 
Age First premolar site Second premolar Site 
CX 13 59.08 ± 7.3 8 5 
CV 13 54.62 ± 8.4 8 5 
3.2. Intra-surgical evaluation 
The results of the intra-surgical evaluation at the IP visit are illustrated in Table 3.2. 
Implants at Group CV had slightly greater mean buccal (2.4±0.7mm vs 1.8±1.0mm, 
p=0.09) and lingual bone thickness (2.3±1.1mm vs 1.6±0.8mm, p=0.06) compared to 
Group CX.  Overall, there were no statistically significant differences between the two 
groups in terms of mucosal thickness, buccal and lingual bone thickness, and distance 






Table 3. 2 Descriptive statistics at Surgery (Mean ± standard deviation, in mm). 




P-value  95% CI 
Mucosal thickness     
Mean (SD) 2.7 (0.6) 3(1.1) 0.50 (-0.93,0.46) 
Min 2 1   
Max 4 5   
Buccal Bone Thickness      
Mean (SD) 1.8(1.0) 2.4 (0.7) 0.09 (-0.94,0.48) 
Min  0.5 0.5   
Max 4 3.5   
Lingual Bone Thickness      
Mean (SD) 1.6 (0.8) 2.3 (1.1) 0.06 (-1.53,-0.01) 
Min  0.5 1   
Max  3 5   
Buccal Subcrestal Position      
Mean (SD) 1.7 (0.5) 1.7 (0.8) 1 (-0.54,0.54) 
Min  1 0   
Max 2.5 3   
Lingual Subcrestal Position 1.1 1.3 0.31 (-0.78,0.32) 
Mean (SD) 0.6 0.7   
Min  0 0   
Max 2 2   
Interproximal Subcrestal 
Position 
    
Mean (SD) 2.4 (0.7) 2.3 (1.1) 0.85 (-0.71,0.75) 
Min 1 0   
Max 4 5   
Keratinized Mucosa Width     
Mean (SD) 2.65 (0.8) 3.69(2.0) 0.09 (-2.28,0.20) 
Min 1 2   
Max 4 9   
 
 
3.3. Clinical evaluations 
The results of clinical evaluations are illustrated in Table 3.3 and Table 3.4. There were 
no statistically significant differences in the percentage of sites with plaque, BoP 
(bleeding on probing), PD (probing depth) at T1 and T2 visits between the two groups. 
There were no statistically significant differences in MP (margin mucosa position) 




in MP observed from T0-T2 which appears to stabilize after 3 months (Figure 3.1). On 
the contrary, a mean increase in MP was observed for the interproximal buccal surfaces 
from T0-T2 (Figure 3.2).  In one patient from the Group CX there was a minor exposure 
of the buccal abutment surface at T1. 
Table 3. 3 Frequency (%) of sites with plaque, BoP, PD ≤3mm, 4 to 5 mm and ≥6mm at 
prosthesis placement (T1) and 1 year following implant installation (T2). 
Group/Time Plaque 
(%) 
BoP (%) PD≤3mm (%) PD 4 to 5mm (%) PD≥6mm (%) 
CX Group/T1 9.6 15.4 84.6 14.1 1.3 
CV Group/T1 9.6 14.1 83.3 14.1 2.6 
CX Group/T2 5.8 16.7 74.4 25.6 - 
CV Group/T2 5.8 10.3 66.7 32.1 1.2 
In CX Group and CC Group, n=52 for Plaque, n=78 for BoP 






















Table 3. 4 Mean Changes (SDs) in peri-implant margin mucosa position (MP) and width 
of keratinized mucosa (KM) (in mm) over time. 








MP Mesial T0-T1 0.3 ± 1.1 0.84 ± 0.89 0.54 0.18 
MP Mesial T0-T2 0.84 ± 1.21 1.46 ± 0.96 0.62 0.16 
MP Mesial T1- T2 0.53 ± 0.51 0.61 ± 0.50 0.8 0.70 
MP Distal T0- T1 0.15 ± 1.0 0.61 ± 1.12 0.46 0.29 
MP Distal T0- T2 0.46 ± 0.96 0.92 ± 1.18 0.46 0.28 
MP Distal T1- T2 0.3 ± 0.48 0.3 ± 0.63 0.00 1.00 
MP Buccal T0- T1 -0.76 ± 0.59 -0.53 ± 0.96 0.23 0.47 
MP Buccal T0- T2 -0.76 ± 0.72 -0.69 ± 0.85 0.07 0.80 
MP Buccal T1- T2 0.0 ± 0.40 -0.15 ± 0.55 -0.15 0.42 
MP Palatal T0- T2 -0.30 ± 0.94 0.07 ± 0.64 0.37 0.23 
MP Palatal  T0- T2 -0.15 ± 0.8 0.15 ± 0.8 0.00 0.33 
MP Palatal T1- T2 0.15 ± 0.37 0.07 ± 0.49 -0.08 0.65 
KM T0- T1 -0.19 ± 0.80 0.15 ± 1.06 0.34 0.36 
KM T0- T2 -0.26 ± 0.72 0.0 ± 1.29 0.26 0.51 
KM T1- T2 -0.07 ± 0.27 -0.15 ± 0.37 -0.08 0.55 
CX: Convex, CV: Concave, T1: Prosthesis delivery, T2: 1-year, MP: Marginal Position 
 
 















Figure 3.2. Mean buccal interproximal mucosal changes with time 
 
3.3.1 Clinical correlation 
The results of correlation analyses are shown in Table 3.5. A Pearson’s r data analysis 
revealed a statistically significant moderate negative correlation between buccal bone 
thickness and recession T0-T2 (r=-0.425, P=0.30). No statistically significant correlation 
was found between buccal bone thickness and mucosal thickness or mucosal thickness 

































1 -0.033 -0.425* 





-0.033 1 -0.048 





-0.425* -0.048 1 
P-value 0.030 0.815  
* P≤0.05 Statistically significant difference between CV and CX 
3.4. Radiographic evaluation 
The mean MBL changes are illustrated in Table 3.6.  There were no statistically 
significant differences in MBL changes at the T0-T1 and T0-T2 between the two groups. 
The mean SP and changes over time are illustrated in Table 3.7 and Figure 3.3. There 
were no statistically significant differences in SP at T0 between groups. However, there 
was a statistically significant difference in SP between CX Group and CV Group at T1 
(0.92±0.43 mm vs 1.22 ±0.55 mm, p=0.02) and T2 (0.66±0.39 mm vs 1.16±0.55 mm, 
p=0.01). In addition, there was a statistically significant difference in the SP change for 
the interval T0-T2 between CX group and CV Group (-0.66±0.46 mm vs -0.24±0.25 mm, 
p=0.007).  
Table 3. 6 Mean changes (SD) in marginal bone level (in mm) over time. 
 T0-T1 T0-T2 
CX  Mean±SD 0 ± 0 0 ± 0 
CV  Mean±SD -0.06 ± 0.24 -0.11 ± 0.40 
P-value 0.76 0.76 





Table 3. 7 Mean subcrestal implant position and changes (SD) (in mm) over time. 
 T0 T1 T2 T0-T1 T0-T2 
CX Mean±SD 1.32 ± 0.43 0.92 ± 0.43 * 0.66 ± 0.39 * -0.40 ± 0.36 -0.66 ± 0.46 * 
CV Mean±SD 1.40 ± 0.57 1.22 ± 0.55 * 1.16 ± 0.55 * -0.17 ± 0.18 -0.24 ± 0.25 * 
P-value 0.362 0.02 0.01 0.06 0.007 
* P≤0.05 Statistically significant difference between CV and CX 
 
Figure 3.3. Mean subcrestal position changes with time 
3.5. CBCT 1-year evaluation 
The results of the CBCT evaluation are in illustrated in Table 3.8. There was a 
statistically significant difference at ST2 between CV and CX Groups (4.08±0.75 vs 3.37 
± 0.81 p=0.03). There was a statistically significant difference at ST3 between CV and 
CX Groups  (2.79 ± 0.66 vs 2.04 ± 0.60 p=0.006). There was a mean difference of 
0.71mm and 0.75mm in the ST2 and ST3 respectively. CV Group had a favorable mean 
difference of 0.22mm in IP-GM, 0.56mm in IP-BC, 0.59mm in BT, 0.68mm in STP and 



















mean difference of 0.33mm in BC-GM, and 0.05mm in ST1 but these were not 
statistically significant.  
Table 3. 8 Descriptive statistics with the mean±SD (mm), mean difference (mm) and P-
value 
 Group Mean ± SD Mean Difference  P-value 
IP-GM CX 3.27 ± 0.78 -0.22 0.621 
CV 3.49 ± 1.34 
IP-BC CX 0.62 ± 0.57 -0.56 0.125 
CV 1.18 ± 1.12 
BC-GM CX 2.65 ± 0.84 0.33 0.253 
CV 2.32 ± 0.62 
ST1 CX 1.79 ± 0.55 0.05 0.816 
CV 1.74 ± 0.45 
BT CX 1.80 ± 0.77 -0.59 0.071 
CV 2.39 ± 0.81 
ST2 CX 3.37 ± 0.81* -0.71 0.03 
CV 4.08 ± 0.75* 
ST3 CX 2.04 ± 0.60* -0.75 0.006 
CV 2.79 ± 0.66* 
STP CX 4.51 ± 0.94 -0.68 0.078 
CV 5.19 ± 0.96 
FirstBiC CX 0.00 ± 0.00 0.15 0.162 
CV -0.15 ± 0.38 
PlatBone CX 0.62 ± 0.51 -0.15 0.416 
CV 0.77 ± 0.44 
AREA CX 5.66 ± 1.97 -1.11 0.304 
CV 6.77 ± 3.26 
* P≤0.05 Statistically significant difference between CV and CX 
3.5.1 CBCT correlation 
The results of the CBCT correlation of soft tissue are shown in Table 3.9. A Pearson’s r 
data analysis revealed a statistically significant moderate positive correlation between the 
following, ST1 and AREA (r=0.506, P≤0.005), ST1 and BC-GM (r=0.456, P≤.005), ST2 
and STP (r=0.481, P≤.005), ST2 and AREA (r=0.573, P≤.005), ST3 and AREA 
(r=0.663, P≤.001), ST3 and STP (r=0.481, P≤.005), STP and AREA (r=0.529, P≤.005), 




Pearson’s r correlation was found in ST2 and ST3 (r=0.738, P≤.001), No other 
statistically significant correlations were found. 
Table 3. 9 CBCT soft tissue correlation 
 ST1 ST2 ST3 STP AREA BC-GM 
ST1 Pearson r 
Correlation 
1 0.368 0.322 0.313 0.506* 0.456* 
P-value  0.064 0.109 0.119 0.008 0.019 
ST2 Pearson r 
Correlation 
0.368 1 0.738* 0.642* 0.573* 0.151 
P-value .064  0 0 0.002 0.461 
ST3 Pearson r 
Correlation 
0.322 0.738* 1 0.481* 0.663* -0.011 
P-value 0.109 0  0.013 0 0.959 
STP Pearson r 
Correlation 
0.313 0.642* 0.481* 1 0.529* 0.312 
P-value .119 0 0.013  0.005 0.121 
AREA Pearson r 
Correlation 
0.506* 0.573* 0.663* 0.529*A 1 0.559* 





0.456* 0.151 -0.011 0.312 0.559** 1 
P-value 0.019 0.461 0.959 0.121 0.003  








3.5.2 Bone remodeling analysis 
Analysis of the mean difference in the surgical bone thickness and implant subcrestal 
buccal position to the CBCT are shown in Table 3.41. There was a statistically significant 
change in subcrestal implant position from T0 to T2 of 1.07±0.28mm and 0.52±0.52 for 
the CX and CV group (P=0.002) respectively with a mean difference of 0.55mm. There 
was no statistically significant change in buccal bone thickness 1mm apical to the bone 
crest for both groups.  
Table 3. 10 Mean buccal subcrestal implant position changes over 1-year. 
 CX  Mean±SD CV  Mean±SD Mean Difference P value 
Bone Thickness 0.05±0.41 0.00±0.70 0.46 0.84 
Subcrestal position 1.07±0.28 0.52±0.52 0.55 0.002 

















The results of the present study demonstrated that there were no statistically significant 
differences in buccal peri-implant margin position between the two groups in 1 year. 
However, abutment macro-design significantly affected the amount of bone remodeling 
above the implant platform for subcrestally placed implants. In addition, the abutment 
macro-design significantly increased the horizontal soft tissue thickness at ST2 and ST3. 
Changes in peri-implant mucosa position over time has been evaluated in several studies. 
105-108 A trend for mucosal tissue recession has been described with major alterations 
occurring during the first three months following connection of the transmucosal 
component of the implant prosthesis complex. Similar findings have been described in 
the current study for the buccal aspect of the study implants. Buccal mucosal recession 
was observed from the time of implant installation to final crown delivery at 3 months 
and at the 12-month follow-up examination. This recession mainly occurred at the first 3 
months with minimal changes thereafter. We observed a different pattern for the 
interproximal surfaces meaning that following surgery; interproximally, there was a 
coronal migration of the peri-implant mucosa margin over time. Interestingly, it appeared 
that greater changes occurred at the interval of 3 months to 12 months for the 
interproximal surfaces compared to buccal surfaces suggesting that healing and 
maturation of the interproximal supracrestal tissues of the adjacent teeth may have a role 
on this dimensional difference between the buccal and interproximal surfaces. One of the 
several challenges evaluating peri-implant mucosa recession after connection of the 
provisional restoration is the difficulty standardizing the location of the peri-implant 




placement of an implant in a healed site and connection of a provisional restoration, the 
mucosa has to be adapted around the provisional restoration.  
In the current study, in order to achieve adaptation, it was not uncommon that a small 
portion of the buccal mucosa had to be excised. Effort was made to avoid advancing the 
flap too far beyond the abutment-crown margin. In the case that coronal advancement of 
the buccal flap occurred, one expects greater buccal mucosa recession during the first 
months of healing. 
It has been proposed by Su, et al. that alterations in the subcritical contour of the 
restoration may modify peri-implant mucosa margin position. In the present study, even 
though we did not observe any significant differences in the peri-implant mucosa position 
changes between implants with convex and concave abutment macro-design, the effect of 
altering the abutment macro-design during treatment was not evaluated. All implants 
maintained the same abutment during surgical and restorative phases of treatment. 109 
For both treatment groups implant placement was planned and performed following 
treatment planning guidelines described previously by Buser, et al., with the implant 
platform positioned 3-4 mm apical to the future crown margin. 8 It is worth noting that all 
implants from both groups with the exception of one implant at Group CV had their 
platforms in a subcrestal position at the buccal aspect of the implant. In addition, all 
interproximal surfaces for implants of both treatment groups had their platforms in a 
subcrestal position. Thus, one should expect that placement of the implant platform will 
be at a subcrestal position for at least one surface when treating patients for single tooth 




specific implant system has been evaluated in both animal and clinical studies. 57, 110-113 In 
general, in those studies, it was observed that subcrestal implant placement can induce 
greater bone remodeling above the implant platform. However, the first bone-to-implant 
contact was located consistently at or on top of the implant platform. Observations from 
previous studies are in agreement with our results which confirm the patterns of bone 
remodeling for the specific implant system when placed in subcrestal position.  
In the current study, comparison of the surgical measurements and 1-year CBCT 
measurements showed that the subcrestal position of the implant measured at the buccal 
position had significantly more bone remodeling around the CX group. CX group had 
0.55mm (P=0.002) more bone remodeling when compared to the CV group during 
surgery and after 1 year at the CBCT. This confirms with our radiographical report where 
we found statistically significant more bone remodeling in the CX group of 0.42mm. This 
finding is in agreement with the animal studies from Finelle, et al. and Souza, et al. In 
both studies, healing abutments with different diameters and emergence profiles were 
used. It was observed that implants connected to abutments with wider diameters and 
emergence profiles experienced greater bone loss compared to implants connected to 
abutments with narrower diameters and emergence profiles. In addition, the peri-implant 
mucosa was established with similar dimensions. 87, 114 The explanation for those 
observations was when using a wide healing abutment, there is a reduction in the space 
available for the peri-implant biologic width to establish. In the current study, the 
diameter of the custom abutments depended the dimensions of the crown. Because all 
teeth included in the study were upper premolars, no major differences in abutment 




contribute to peri-implant bone remodeling. Since implants with convex abutments 
experienced greater bone remodeling above the implant platform compared to implants 
with concave abutments might suggest that abutment macro-design can have an effect on 
establishment of the biologic width and consequently on the amount of bone remodeling. 
For the CBCT analysis, the bone thickness was larger in the CX group but was not 
statistically significant. The difference in bone thickness measured 1mm apical to the 
crest during surgery and 1 year at the CBCT evaluation did not change significantly for 
both groups (0mm for CV and 0.05mm for CX). This was different to a study by Vera et 
al. which found that 1mm apical to the implant, 0.62mm of horizontal bone loss occurred. 
This difference could be attributed to the difference in methodology and/or 
implant/abutment design. 99 The mean bone thickness at T0 was 2.5mm and 1.9mm for 
the CX and CV groups respectively. Cho et al. suggested a bone thickness of 1.91mm is 
recommended to reduce the incidence of bone resorption in the anterior maxilla whereas 
Spray et al. suggested a minimum bone thickness of 2mm is needed to reduce bone loss. 
100 115  
The effect of abutment design on peri-implant tissue changes has been evaluated in few 
clinical studies. Patil et al. reported that implants with conventional divergent shape have 
similar marginal bone level changes and peri-implant mucosa level changes compared to 
implants with curved and grooved abutments. 91 Katafuchi et al. reported that implants 
with restorations characterized by wide emergence angle (greater than 30°) and convex 
profile had higher rate of peri-implantitis compared to implants with a narrow emergence 
angle (less than 30°) and straight or concave profile. Those findings were attributed to 




maintenance procedures. 116 Interestingly, Sancho-Puchades et al. in a laboratory study 
reported that abutments with a concave emergence profile and deep crown-abutment 
margin positions are in greater risk to have cement excess following the crown 
cementation, which can potentially lead to peri-implant tissue inflammation. 62 In the 
current study, we did not observe any significant differences in clinical indices between 
the two groups of implants and any incidence of peri-implantitis. However, one should 
consider the short-term follow-up time. In the present study, we observed a significant 
correlation between changes of the buccal peri-implant margin position from T0 to T2 
and buccal bone thickness at the time of the surgery irrespective from the abutment 
macro-design. A positive effect of buccal bone thickness and/or integrity on peri-implant 
mucosa levels for immediate implants have been reported by Benic et al. 103 However, we 
did not observe a significant correlation between the mucosa thickness at the time of the 
surgery and changes of the buccal peri-implant margin position. In the current study, we 
used a similar way to measure mucosa thickness as previously described by Linkevicius 
et al. 117 In this study and in subsequent studies, it was demonstrated that mucosa 
thickness can influence peri-implant bone remodeling and the authors recommended a 
minimum of 2mm of vertical soft tissue thickness. In our study, the vertical soft tissue 
thickness measured at T0 was 2.82mm and 3.00mm for CV and CX group respectively. 
As such, the gingival biotype for all patients except one was determined to be thick 
(≥2mm) when measured at T0.  118, 119 
In our study CBCT analysis of the horizontal soft tissue thickness was significantly 
greater at the ST2 and ST3 in the concave definitive abutments. This cannot be attributed 




groups in the soft tissue clinical measurements and the ST1 in the CBCT scan. In 
addition, the vertical thickness of the soft tissue was also similar between the two groups. 
At ST3 a mean increase in soft tissue thickness of 0.75mm was found for the CV group, 
meaning a 37% more horizontal soft tissue thickness in the CV group. Whereas in ST2, 
an increase of 0.71mm was found for the CV group, or a 21% more horizontal soft tissue 
thickness in the CV group. The difference between the percentage in these 2 areas could 
be attributed to that there is a greater difference between the width of the healing 
abutments as you go more coronally, giving more space for soft tissue to take up this 
space. Also, at ST2, 8 of the 26 implants had the ST2 measured at the implant-abutment 
interface, which we do not expect to see the difference in soft tissue thickness at this area. 
There was also an increase in the true height (0.68mm) and area(1.11mm2) of the CV 
group but was not statistically significant. The HT and AREA both had moderate 
correlations to other factors than the ST2 and ST3 which could be the reason why this 
was not found to be statistically significant. Limited data is available on the effects of 
horizontal soft tissue thickness on peri-implant soft and hard tissue. In addition, whether 
horizontal and vertical soft tissue thickness affect the peri-implant hard and soft tissue as 
two different entities or are a continuation of each other is unknown. However, in our 
study there was a moderate correlation found between horizontal and vertical soft tissue 
thickness when measured with the CBCT scan. Peri-implant diseases and conditions 
consensus report by Berglundh et al indicated that thin soft tissue is one of the risk factors 
for recession. 120 In immediate implant placement, several studies have associated the risk 
of thin soft tissue biotype with recession by assessing the thickness using a periodontal 




121, 122 However, Cosyn et al found that, even with thick gingival biotype, immediate 
implants still had mid facial recession. 123   
An in vitro study by Jung et al evaluated different abutment materials under different soft 
tissue thickness in pigs to assess the effect on the color of mucosa. The study found that 
at 1.5mm thickness, all materials affected the color change and for 2mm only titanium 
affected the color. Whereas in thick 3mm thickness, no changes were observed for all 
materials. 124 Jung et al. evaluated the thickness of the midfacial mucosa 1mm apical to 
the gingival margin and found it to be 2.6mm in the Porcelain fused to metal group with 
titanium or gold abutments and 3.2mm in the all-ceramic crowns on aluminum-oxide 
based abutments. 125 Chang et al. found the horizontal mucosal thickness at the base of 
the pocket to be 2mm in implants. 126 A study by Benic et al. found the mucosal thickness 
measured using the application of composite layer on CBCT to be 1.5mm when measured 
1mm apical to the gingival margin. In addition, 5 of the 14 implants showed loss of 
buccal bone on the CBCT. To our knowledge, this is the only study evaluated soft and 
hard tissue dimensions using the application of a composite layer. The difference in 
horizontal soft tissue thickness in these studies and our current study can be attributed to 
the different methodology used. For example, there was a difference in the location of 
measurement of the horizontal soft tissue thickness. In our study, the mean distance 
measured from the gingival margin to ST2 and ST3 was measured on average 2.49mm 
and 1.26mm respectively.  
In the present study we avoided any abutment disconnections after the surgical phase of 
the treatment, in order to maximize peri-implant bone stability. Recent systematic 




of the final abutment on peri-implant bone levels. 57, 59 To our knowledge this is the first 
clinical study utilizing custom CAD-CAM abutments as opposed to prefabricated 
standard abutments for this application. One major limitation of the study was the loss of 
two participants, without an increase to the sample size in order to compensate for that. 
This resulted in reduction of the study power. In addition, comparing the intra surgical 
data with the CBCT data should be interrupted with caution due to the effect of artifacts.  
5. Conclusion 
Within the limitation of this study, the following conclusions can be drawn: 
1. The null hypothesis was rejected for hard tissue as more bone remodeling was 
observed for the convex group 
2. The null hypothesis was accepted for soft tissue as no difference in peri-implant 
mucosal position was seen between the two groups. 
3. There were no statistically significant differences in buccal peri-implant margin 
position between the two groups in 1 year 
4. There was a statistically significant difference between the subcrestal position of 
the CX and CV group during the 1-year evaluation (Statistically significant more 
bone remodeling occurred in the CX group) 
5. Horizontal soft tissue thickness was significantly greater at ST2 and ST3 for the 
CV group in the CBCT analysis 
6. There was a statistically significant moderate correlation between buccal bone 











Patient number Group  
1: Convex  
2: Concave 
Implant Site Age Gender 
1 1 13 66 F 
2 1 4 60 F 
3 1 12 65 F 
4 1 13 71 F 
5 1 12 63 M 
6 1 12 57 F 
7 1 12 51 F 
8 1 4 52 F 
9 1 12 46 F 
10 1 5 50 M 
11 1 12 65 F 
12 1 4 61 F 
13 1 12 61 F 
14 2 5 36 M 
15 2 4 54 M 
16 2 5 57 M 
17 2 12 50 M 
18 2 13 57 F 
19 2 5 49 F 
20 2 13 61 F 
21 2 13 61 F 
22 2 4 50 F 
23 2 5 63 M 
24 2 5 46 M 
25 2 12 58 F 

















1 1 2 1.5 0.5 2 
2 1 3 1 2 1 
3 1 3 3 1 4 
4 1 4 0.5 3 3 
5 1 2 2 2 3 
6 1 3 1 1 2 
7 1 3 1 1 3 
8 1 3 4 3 3 
9 1 3 1 1 3 
10 1 2 2 2 3 
11 1 3 3 1 3 
12 1 3 2 2 1.5 
13 1 2 2 1 3 
14 2 5 2 1.5 9 
15 2 4 3.5 5 2 
16 2 2 2 3 4 
17 2 4 0.5 1 5 
18 2 3 3 3 2 
19 2 4 3 2 4 
20 2 1 2 1 3 
21 2 2 3 2 3 
22 2 3 2 3 2 
23 2 3 3 2 3 
24 2 3 3 3 6 
25 2 3 2 2 3 






















Peri-bone implant measurement Stent measurement on the buccal 
M D B P DB Mid-B MB 
1 1 2 2 2 1.5 4 6 5 
2 1 2 1 1 1 4 8 4 
3 1 2 2 2 1 7 7 7 
4 1 1.5 1 1 1 9 9 9 
5 1 3 2 1.5 2 9 9 8 
6 1 3 3 1.5 1 6 9 6 
7 1 3 3 1 1 9 10 9 
8 1 3 3 2.5 1 8 9 9 
9 1 3 4 2 2 8 9 9 
10 1 3 3 2 2 6 9 9 
11 1 3 1 2 1 8 9 8 
12 1 2 2 1.5 0.5 5 5 5 
13 1 2 2 2 0 7 9 9 
14 2 3 2 3 1 7 10 8 
15 2 3 3 3 2 5 6 5 
16 2 1 2 1 1 5 7 6 
17 2 0 0 0 0 4 2 3 
18 2 2 2 2 2 4 6 5 
19 2 5 3 1.5 2 4 5 6 
20 2 1 1 1 1 7 9 9 
21 2 3 3 2 2 9 9 9 
22 2 2 2 1 2 7 8 8 
23 2 3 3 2 2 7 9 7 
24 2 2 2 1.5 1 9 11 9 
25 2 3 4 2 2 9 9 8 






















Probing depth (PD) measurement Stent measurement on the buccal 
DB Mid-B MB DB Mid-B MB 
1 1 2 1 2 5 7 7 
2 1 4 2 2 5 9 5 
3 1 3 1 2 5 7 6 
4 1 1 1 2 8 11 8 
5 1 3 1 2 10 10 8 
6 1 2 2 3 5 9 5 
7 1 3 1 3 8 11 8 
8 1 2 2 3 7 9 7 
9 1 3 2 2 8 10 10 
10 1 3 2 3 6 10 8 
11 1 2 2 2 8 10 8 
12 1 3 3 3 5 6 5 
13 1 4 4 3 8 9 9 
14 2 3 3 3 10 11 8 
15 2 3 3 4 4 7 5 
16 2 2 1 2 4 8 6 
17 2 2 3 3 3 3 3 
18 2 3 3 3 4 7 4 
19 2 3 2 4 3 4 4 
20 2 4 4 3 7 10 8 
21 2 3 2 3 9 10 9 
22 2 3 1 3 6 7 6 
23 2 2 2 3 8 10 5 
24 2 3 2 3 8 10 8 
25 2 3 2 3 8 10 7 




















Bleeding on Probing (BOP) 
Keratinized 
Mucosa 





DB Mid-B MB 
1 1 0 0 0 2 0 
2 1 1 0 0 1 0 
3 1 0 0 0 3 0 
4 1 0 0 0 2 0 
5 1 1 0 0 3 0 
6 1 0 0 1 3 0 
7 1 0 0 0 2 1 
8 1 0 0 1 4 0 
9 1 0 0 0 4 0 
10 1 0 0 0 3 0 
11 1 0 0 0 4 0 
12 1 0 0 0 1 0 
13 1 1 1 1 3 0 
14 2 0 0 0 9 0 
15 2 1 0 0 2 0 
16 2 0 0 0 4 0 
17 2 0 0 0 3 0 
18 2 0 0 0 3 0 
19 2 0 0 1 4 0 
20 2 0 1 0 3 0 
21 2 0 0 0 3 0 
22 2 3 1 3 6 7 
23 2 2 2 3 8 10 
24 2 3 2 3 8 10 
25 2 3 2 3 8 10 






















Probing depth (PD) 
measurement 
Stent measurement on 
the palatal 









1 1 2 2 2 5 5 5 0 0 0 
2 1 4 2 2 7 8 7 1 0 0 
3 1 3 2 3 6 7 6 1 0 0 
4 1 3 1 3 9 9 8 0 0 1 
5 1 4 2 3 9 9 7 1 0 0 
6 1 3 2 3 7 8 6 1 0 0 
7 1 5 2 2 7 8 8 0 0 0 
8 1 2 2 3 6 8 6 0 0 0 
9 1 2 2 3 9 9 8 0 0 0 
10 1 4 2 4 5 6 5 0 0 0 
11 1 4 3 3 6 7 6 0 0 0 
12 1 3 3 3 5 6 5 0 0 0 
13 1 3 2 3 8 8 7 0 0 0 
14 2 4 4 4 5 7 5 0 0 0 
15 2 5 2 2 5 7 5 0 0 0 
16 2 3 1 2 11 11 11 0 0 0 
17 2 2 2 3 3 3 3 0 0 0 
18 2 3 3 3 6 6 5 0 0 0 
19 2 3 2 3 5 6 5 1 0 0 
20 2 3 2 2 9 9 8 0 0 1 
21 2 3 2 2 9 9 8 0 0 0 
22 2 3 2 4 6 7 6 0 0 0 
23 2 4 2 3 7 9 7 0 0 0 
24 2 3 2 3 7 7 6 1 0 0 
25 2 3 2 3 5 7 5 1 0 1 



















Plaque score on the Buccal, Mesial, 
Distal, and palatal 
Probing depth (PD) measurement 
M D B P DB Mid-B MB 
1 1 0 0 0 0 2 1 2 
2 1 1 0 0 0 3 3 3 
3 1 0 1 0 0 4 2 3 
4 1 0 0 0 0 4 2 4 
5 1 1 1 0 0 3 1 2 
6 1 0 0 0 0 2 2 3 
7 1 0 0 0 0 4 2 3 
8 1 0 0 0 0 2 2 3 
9 1 0 0 0 0 2 1 2 
10 1 0 0 0 0 3 2 4 
11 1 0 1 0 0 3 1 3 
12 1 0 0 0 0 3 3 3 
13 1 0 0 0 0 4 3 3 
14 2 0 0 0 0 2 1 2 
15 2 0 0 0 0 4 3 3 
16 2 1 0 0 0 2 1 3 
17 2 0 0 0 0 2 3 3 
18 2 1 1 0 0 3 3 3 
19 2 0 0 0 0 4 2 4 
20 2 0 0 0 0 5 3 4 
21 2 0 0 0 0 3 2 3 
22 2 1 0 0 0 3 2 3 
23 2 1 0 0 0 3 2 4 
24 2 0 0 0 0 3 2 3 
25 2 0 0 0 0 3 2 3 
























DB Mid-B MB 
1 1 0 0 0 3 0 
2 1 0 1 0 2 0 
3 1 0 0 0 3 0 
4 1 1 0 1 2 0 
5 1 0 0 0 3 0 
6 1 0 0 1 3 0 
7 1 0 0 0 3 1 
8 1 0 0 1 4 0 
9 1 0 0 1 4 0 
10 1 0 0 1 3 0 
11 1 0 0 0 2 0 
12 1 0 0 0 2 0 
13 1 0 1 0 3 0 
14 2 0 0 0 8 0 
15 2 0 0 1 3 0 
16 2 0 0 1 3 0 
17 2 0 0 1 3 0 
18 2 1 0 1 3 0 
19 2 0 0 0 4 0 
20 2 1 0 1 3 0 
21 2 0 0 0 3 0 
22 2 0 0 0 2 0 
23 2 0 0 0 5 0 
24 2 0 0 0 5 0 
25 2 1 0 0 2 0 



















Probing depth (PD) 
measurement 
Stent measurement 
on the palatal 
Bleeding on Probing 
(BOP) 







1 1 2 2 3 5 5 5 0 0 0 
2 1 4 2 3 7 8 7 0 0 0 
3 1 3 2 4 6 7 6 0 0 0 
4 1 3 2 3 8 9 8 1 0 1 
5 1 3 2 3 9 9 7 0 0 0 
6 1 2 2 3 7 8 6 1 0 0 
7 1 3 2 4 7 8 7 0 0 0 
8 1 2 2 3 6 8 6 0 0 0 
9 1 2 2 2 9 9 8 0 0 0 
10 1 6 2 4 5 7 5 0 0 1 
11 1 3 2 4 6 7 6 0 0 0 
12 1 3 3 3 5 6 5 0 0 0 
13 1 3 2 3 8 8 7 0 0 0 
14 2 4 3 3 5 7 5 0 0 0 
15 2 4 2 4 6 7 6 0 0 0 
16 2 2 1 2 11 11 11 0 0 0 
17 2 2 2 3 3 3 3 0 0 0 
18 2 3 3 3 6 6 5 0 0 1 
19 2 6 3 4 5 6 5 0 0 0 
20 2 3 2 2 9 9 7 0 0 0 
21 2 2 2 2 9 9 8 0 0 0 
22 2 3 2 4 6 6 5 0 0 0 
23 2 3 2 6 7 9 7 0 0 1 
24 2 3 3 3 7 7 6 0 0 1 
25 2 2 2 2 5 7 5 0 0 0 





















Plaque score on the 
Buccal, Mesial, Distal, 
and palatal 
Probing depth (PD) 
measurement 
Stent measurement on 
the buccal 
M D B P DB Mid-B MB DB Mid-
B 
MB 
1 1 0 0 0 0 3 2 3 5 7 7 
2 1 0 0 0 0 3 2 2 5 9 5 
3 1 1 1 0 0 5 1 3 5 7 6 
4 1 1 0 0 0 3 3 3 8 11 8 
5 1 1 1 0 0 3 1 2 9 9 7 
6 1 0 0 0 0 4 2 4 5 9 5 
7 1 0 1 0 0 3 3 3 8 11 7 
8 1 0 0 0 0 2 2 4 7 9 7 
9 1 0 1 0 0 4 2 3 8 11 9 
10 1 0 0 0 0 3 2 4 6 10 7 
11 1 1 1 0 0 2 2 3 8 10 7 
12 1 0 0 0 0 4 3 3 3 6 3 
13 1 0 0 0 0 4 3 4 7 9 8 
14 2 0 0 0 0 4 2 3 8 11 7 
15 2 0 0 0 0 5 4 5 3 7 4 
16 2 0 0 0 0 5 1 3 4 8 5 
17 2 0 0 0 0 2 3 3 3 3 3 
18 2 0 1 0 0 4 2 3 4 7 4 
19 2 0 1 0 0 4 2 4 3 4 3 
20 2 0 0 0 0 5 2 3 6 10 7 
21 2 0 0 0 0 3 3 3 10 11 9 
22 2 1 0 0 0 3 2 4 6 9 6 
23 2 1 0 0 0 3 2 4 7 9 4 
24 2 0 0 0 0 4 3 4 7 10 7 
25 2 0 0 0 0 3 2 3 6 10 6 
























DB Mid-B MB 
1 1 0 1 0 
3 
0 
2 1 0 0 1 2 0 
3 1 0 0 0 3 0 
4 1 0 0 0 2 0 
5 1 0 0 0 3 0 
6 1 1 0 1 3 0 
7 1 0 0 0 3 1 
8 1 0 0 0 4 0 
9 1 1 0 0 4 0 
10 1 1 0 0 
3 
0 
11 1 0 0 0 
3 
0 
12 1 1 0 0 
2 
0 
13 1 0 0 1 
3 
0 
14 2 0 0 0 8 0 
15 2 0 0 1 4 0 
16 2 0 0 0 3 0 
17 2 0 0 1 3 0 
18 2 1 0 0 4 0 
19 2 0 0 0 4 0 
20 2 0 0 0 3 0 
21 2 1 0 0 3 0 
22 2 0 0 0 
2 
0 
23 2 1 0 0 
5 
0 
24 2 0 0 0 5 0 
25 2 0 0 0 
2 
0 




















Probing depth (PD) 
measurement 
Stent measurement on 
the palatal 
Bleeding on Probing 
(BOP) 
DP Mid-P MP DP Mid-P MP DP Mid-P MP 
1 1 3 2 3 5 5 5 0 0 0 
2 1 5 2 3 7 8 7 1 1 0 
3 1 3 2 3 6 7 6 0 0 0 
4 1 3 3 3 8 9 8 0 0 0 
5 1 3 2 5 8 8 6 0 0 0 
6 1 3 2 3 7 8 6 0 0 0 
7 1 2 3 3 7 8 7 0 0 0 
8 1 4 3 5 6 8 6 1 0 0 
9 1 3 2 4 9 9 8 1 0 0 
10 1 4 2 2 5 7 5 0 0 0 
11 1 3 3 4 6 7 6 0 0 0 
12 1 3 2 3 5 6 5 1 0 0 
13 1 5 4 3 7 7 6 0 0 0 
14 2 4 5 4 5 7 5 0 0 0 
15 2 6 4 5 6 7 6 0 0 0 
16 2 3 2 3 11 11 11 0 0 0 
17 2 2 2 3 3 3 3 0 0 0 
18 2 3 2 3 6 5 5 0 0 0 
19 2 4 3 4 5 6 5 1 0 0 
20 2 3 2 3 9 9 7 0 0 0 
21 2 3 3 3 9 10 9 1 0 0 
22 2 4 3 3 6 6 5 0 0 0 
23 2 4 2 2 6 9 7 0 0 0 
24 2 3 2 3 6 6 5 0 0 1 
25 2 3 2 4 5 7 5 0 0 0 

































Radiographic subcrestal position 
At surgery day At 3 months At 1-year 
Mesial Distal Mesial Distal Mesial Distal 
1 1 1.81 2.5 0.76 1.09 0.69 0.89 
2 1 1.81 1.26 0.96 0.66 0 0.66 
3 1 0.75 1.03 1.04 0.94 1.09 0.94 
4 1 1.51 1.35 1.51 1.08 0.8 0.8 
5 1 1.22 1.08 1.2 0.8 1.2 0.8 
6 1 1.26 1.44 0.88 0.66 0 0 
7 1 2.32 1.89 2.04 1.71 1.35 1.08 
8 1 1.53 1.07 1.1 0.91 0.72 0.66 
9 1 1.12 2 0.85 1.38 0.8 1.2 
10 1 1.2 0.96 0.76 0.72 0.76 0.72 
11 1 1.2 1.01 1.15 0.83 1 0.5 
12 1 0.67 1.17 0 0 0 0 
13 1 0.7 0.7 0.6 0.3 0.3 0.3 
14 2 2.31 2.14 2.31 2.14 2.31 2.14 
15 2 2.16 1.4 2.16 1.4 2.16 1.4 
16 2 1.3 1.45 0.89 1.15 0.89 1.15 
17 2 0 0 0 0 0 0 
18 2 1.35 1.47 1.35 1.47 1.35 1.47 
19 2 1.46 2.08 1.46 1.98 1.3 1.82 
20 2 0.58 0.78 0.58 0.51 0.58 0.51 
21 2 2.12 1.91 1.46 1.29 1.2 1.1 
22 2 1.18 1.1 1.18 0.89 1.18 0.89 
23 2 1.68 1.65 1.4 1.4 1.4 1.4 
24 2 1.47 1.44 0.94 1.44 0.9 1.1 
25 2 1.5 1.26 1.1 1.13 1.1 1.1 






















Radiographic Bone to first implant contact  
At surgery day At 3 months At 1 year 
Mesial Distal Mesial Distal Mesial Distal 
1 1 0 0 0 0 0 0 
2 1 0 0 0 0 0 0 
3 1 0 0 0 0 0 0 
4 1 0 0 0 0 0 0 
5 1 0 0 0 0 0 0 
6 1 0 0 0 0 0 0 
7 1 0 0 0 0 0 0 
8 1 0 0 0 0 0 0 
9 1 0 0 0 0 0 0 
10 1 0 0 0 0 0 0 
11 1 0 0 0 0 0 0 
12 1 0 0 0 0 0 0 
13 1 0 0 0 0 0 0 
14 2 0 0 0 0 0 0 
15 2 0 0 0 0 0 0 
16 2 0 0 0 0 0 0 
17 2 0 0 -0.65 -1.15 -1.1 -1.84 
18 2 0 0 0 0 0 0 
19 2 0 0 0 0 0 0 
20 2 0 0 0 0 0 0 
21 2 0 0 0 0 0 0 
22 2 0 0 0 0 0 0 
23 2 0 0 0 0 0 0 
24 2 0 0 0 0 0 0 
25 2 0 0 0 0 0 0 









IP-GM IP-BC BC-GM ST1 BT ST2 
1 1 2.3 0.5 1.9 2 1.3 3.3 
2 1 2.1 0 2.1 1.1 0.9 2.5 
3 1 3.6 0.7 3 1.4 2.4 3.8 
4 1 4.1 0 4.1 2.5 0.7 3.4 
5 1 2.5 0.8 1.7 1.2 2.2 3.1 
6 1 3.8 0 3.8 2.3 1 3.5 
7 1 3 0 3 2.1 1.7 2.6 
8 1 3.3 1.8 1.5 1.7 3.3 4.5 
9 1 4.1 0.9 3.2 1.3 1 1.7 
10 1 3.6 1.2 2.4 2 2.4 3.5 
11 1 2.6 0.8 1.8 1.2 2.4 3.2 
12 1 2.9 0.2 2.6 1.6 2.1 4 
13 1 4.6 1.2 3.4 2.8 2 4.7 
14 2 4.9 2.8 2.1 2.1 3.5 4.9 
15 2 5.5 2.8 2.7 1.4 4 4.8 
16 2 2.6 0.1 2.7 1.3 2.3 4.7 
17 2 0.5 -1.2 1.6 2 0.9 2.8 
18 2 3.1 1.1 2 1.5 2.4 3.3 
19 2 5.2 2.1 3.1 1.8 2.2 4.4 
20 2 3.6 0.6 3 2.2 2.8 4.7 
21 2 3.9 2.1 1.8 1.2 2.7 3.6 
22 2 2.4 0.6 1.8 1.1 1.3 3 
23 2 3.9 1.6 2.3 1.3 2.3 3.7 
24 2 4 0.6 3.4 2.3 2.4 5 
25 2 2.6 1.2 1.4 2.2 1.9 3.8 

















Appendix O: CBCT analysis (raw data) 2 
Patient Number Group Number ST3 STP fBIC Bone on platform AREA 
1 1 1.9 4 0 1 5.6 
2 1 1.6 2.9 0 0 4 
3 1 1.8 5.8 0 1 7.2 
4 1 1.7 5 0 0 7.2 
5 1 1.6 3.5 0 1 3.2 
6 1 2.2 5 0 0 7.5 
7 1 1.6 3.6 0 0 4.2 
8 1 3.5 5.3 0 1 5.7 
9 1 1.4 4.8 0 1 4.5 
10 1 2.6 4.4 0 1 5.2 
11 1 1.6 3.9 0 1 3.4 
12 1 2.3 4.3 0 0 5.7 
13 1 2.7 6.1 0 1 10.2 
14 2 3.5 6.5 0 1 6.7 
15 2 2 6.7 0 1 6.4 
16 2 3.5 5 -0.8 0 7.3 
17 2 2.8 5.1 -1.2 0 8 
18 2 2.2 4.4 0 1 3.4 
19 2 3.7 6.6 0 1 11.4 
20 2 3.9 4.3 0 1 13.8 
21 2 2.5 5.2 0 1 4.7 
22 2 2 3.5 0 1 2.8 
23 2 2.3 5.1 0 1 6.4 
24 2 2.9 5.6 0 0 9.2 
25 2 2.3 5 0 1 3.2 
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